"alt_sample_name"	"unique_patient_ID"	"sample_type"	"histological_type"	"primarysite"	"arrayedsite"	"summarygrade"	"summarystage"	"tumorstage"	"substage"	"grade"	"age_at_initial_pathologic_diagnosis"	"pltx"	"tax"	"neo"	"days_to_tumor_recurrence"	"recurrence_status"	"days_to_death"	"vital_status"	"os_binary"	"relapse_binary"	"site_of_tumor_first_recurrence"	"primary_therapy_outcome_success"	"debulking"	"percent_normal_cells"	"percent_stromal_cells"	"percent_tumor_cells"	"batch"	"uncurated_author_metadata"
"GSM311938"	"26DC"	NA	"tumor"	"ser"	"ov"	NA	NA	"late"	3	"c"	NA	41	"y"	NA	NA	NA	NA	NA	NA	"short"	NA	NA	NA	"suboptimal"	NA	NA	NA	NA	"title: 26DC///geo_accession: GSM311938///status: Public on Aug 12 2008///submission_date: Aug 12 2008///last_update_date: Aug 13 2008///type: RNA///channel_count: 2///source_name_ch1: serous ovarian adenocarcinoma///organism_ch1: Homo sapiens///characteristics_ch1: fresh frozen tumour///characteristics_ch1.1: deceased///characteristics_ch1.2: stage IIIc///characteristics_ch1.3: macroscopic residual tumor///characteristics_ch1.4: age at diagnosis 41///characteristics_ch1.5: post surgical chemo therapy farmorubicine, carboplatin and cyclophosphamide///molecule_ch1: total RNA///extract_protocol_ch1: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch1: Cy3///label_protocol_ch1: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch1: 9606///source_name_ch2: Universal Human Reference RNA purchased from Stratagene///organism_ch2: Homo sapiens///characteristics_ch2: Reference///molecule_ch2: total RNA///extract_protocol_ch2: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch2: Cy5///label_protocol_ch2: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch2: 9606///hyb_protocol: The probes were purified using ChipShot labelling cleanup system (Promega). The hybridizations were carried out using Pronto! Micro Array reagent systems (Corning Inc.). For each sample, labelled tumour cDNA and reference cDNA were co-precipitated and hybridised to the oligoarray slide.  After hybridization, slides were washed sequential.///scan_protocol: Scanned on an Agilent G2565AA scanner.///scan_protocol.1: Images were quantified using Genepix 6.0.0.74 (Axon Instruments).///description: Comparison of ovarian tumors of 5 year survivors to deceased patients///data_processing: Intensities were calculated by mean spot - median background. Flagged spots were removed as well as spots with intensities below 20 in both channels. Intensities below 20 in one channel were set to 20 to compensate for extreme quotients. Loess normalization was used///platform_id: GPL5886///contact_name: Karolina,,Partheen///contact_email: karolina.partheen@gu.se///contact_phone: +46+31 342 78 55///contact_fax: +46 +31 41 72 05///contact_department: department of Oncology///contact_institute: University of Gothenburg///contact_address: Bl Strket 2///contact_city: Gothenburg///contact_zip.postal_code: 413 45///contact_country: Sweden///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM311nnn/GSM311938/GSM311938.gpr.gz///data_row_count: 30000"
"GSM311939"	"45LA0"	NA	"tumor"	"ser"	"ov"	NA	NA	"late"	3	"b"	NA	43	"y"	NA	NA	NA	NA	NA	NA	"long"	NA	NA	NA	"optimal"	NA	NA	NA	NA	"title: 45LA0///geo_accession: GSM311939///status: Public on Aug 12 2008///submission_date: Aug 12 2008///last_update_date: Aug 13 2008///type: RNA///channel_count: 2///source_name_ch1: serous ovarian adenocarcinoma///organism_ch1: Homo sapiens///characteristics_ch1: fresh frozen tumour///characteristics_ch1.1: 5 year survivor///characteristics_ch1.2: stage IIIab///characteristics_ch1.3: no macroscopic residual tumor///characteristics_ch1.4: age at diagnosis 43///characteristics_ch1.5: post surgical chemo therapy farmorubicine, carboplatin and cyclophosphamide///molecule_ch1: total RNA///extract_protocol_ch1: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch1: Cy3///label_protocol_ch1: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch1: 9606///source_name_ch2: Universal Human Reference RNA purchased from Stratagene///organism_ch2: Homo sapiens///characteristics_ch2: Reference///molecule_ch2: total RNA///extract_protocol_ch2: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch2: Cy5///label_protocol_ch2: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch2: 9606///hyb_protocol: The probes were purified using ChipShot labelling cleanup system (Promega). The hybridizations were carried out using Pronto! Micro Array reagent systems (Corning Inc.). For each sample, labelled tumour cDNA and reference cDNA were co-precipitated and hybridised to the oligoarray slide.  After hybridization, slides were washed sequential.///scan_protocol: Scanned on an Agilent G2565AA scanner.///scan_protocol.1: Images were quantified using Genepix 6.0.0.74 (Axon Instruments).///description: Comparison of ovarian tumors of 5 year survivors to deceased patients///data_processing: Intensities were calculated by mean spot - median background. Flagged spots were removed as well as spots with intensities below 20 in both channels. Intensities below 20 in one channel were set to 20 to compensate for extreme quotients. Loess normalization was used///platform_id: GPL5886///contact_name: Karolina,,Partheen///contact_email: karolina.partheen@gu.se///contact_phone: +46+31 342 78 55///contact_fax: +46 +31 41 72 05///contact_department: department of Oncology///contact_institute: University of Gothenburg///contact_address: Bl Strket 2///contact_city: Gothenburg///contact_zip.postal_code: 413 45///contact_country: Sweden///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM311nnn/GSM311939/GSM311939.gpr.gz///data_row_count: 30000"
"GSM311940"	"46LB0"	NA	"tumor"	"ser"	"ov"	NA	NA	"late"	3	"b"	NA	43	"y"	NA	NA	NA	NA	NA	NA	"long"	NA	NA	NA	"optimal"	NA	NA	NA	NA	"title: 46LB0///geo_accession: GSM311940///status: Public on Aug 12 2008///submission_date: Aug 12 2008///last_update_date: Aug 13 2008///type: RNA///channel_count: 2///source_name_ch1: serous ovarian adenocarcinoma///organism_ch1: Homo sapiens///characteristics_ch1: fresh frozen tumour///characteristics_ch1.1: 5 year survivor///characteristics_ch1.2: stage IIIab///characteristics_ch1.3: no macroscopic residual tumor///characteristics_ch1.4: age at diagnosis 43///characteristics_ch1.5: post surgical chemo therapy farmorubicine, carboplatin and cyclophosphamide///molecule_ch1: total RNA///extract_protocol_ch1: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch1: Cy3///label_protocol_ch1: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch1: 9606///source_name_ch2: Universal Human Reference RNA purchased from Stratagene///organism_ch2: Homo sapiens///characteristics_ch2: Reference///molecule_ch2: total RNA///extract_protocol_ch2: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch2: Cy5///label_protocol_ch2: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch2: 9606///hyb_protocol: The probes were purified using ChipShot labelling cleanup system (Promega). The hybridizations were carried out using Pronto! Micro Array reagent systems (Corning Inc.). For each sample, labelled tumour cDNA and reference cDNA were co-precipitated and hybridised to the oligoarray slide.  After hybridization, slides were washed sequential.///scan_protocol: Scanned on an Agilent G2565AA scanner.///scan_protocol.1: Images were quantified using Genepix 6.0.0.74 (Axon Instruments).///description: Comparison of ovarian tumors of 5 year survivors to deceased patients///data_processing: Intensities were calculated by mean spot - median background. Flagged spots were removed as well as spots with intensities below 20 in both channels. Intensities below 20 in one channel were set to 20 to compensate for extreme quotients. Loess normalization was used///platform_id: GPL5886///contact_name: Karolina,,Partheen///contact_email: karolina.partheen@gu.se///contact_phone: +46+31 342 78 55///contact_fax: +46 +31 41 72 05///contact_department: department of Oncology///contact_institute: University of Gothenburg///contact_address: Bl Strket 2///contact_city: Gothenburg///contact_zip.postal_code: 413 45///contact_country: Sweden///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM311nnn/GSM311940/GSM311940.gpr.gz///data_row_count: 30000"
"GSM311941"	"47DC"	NA	"tumor"	"ser"	"ov"	NA	NA	"late"	3	"c"	NA	56	"y"	NA	NA	NA	NA	NA	NA	"short"	NA	NA	NA	"suboptimal"	NA	NA	NA	NA	"title: 47DC///geo_accession: GSM311941///status: Public on Aug 12 2008///submission_date: Aug 12 2008///last_update_date: Aug 13 2008///type: RNA///channel_count: 2///source_name_ch1: serous ovarian adenocarcinoma///organism_ch1: Homo sapiens///characteristics_ch1: fresh frozen tumour///characteristics_ch1.1: deceased///characteristics_ch1.2: stage IIIc///characteristics_ch1.3: macroscopic residual tumor///characteristics_ch1.4: age at diagnosis 56///characteristics_ch1.5: post surgical chemo therapy farmorubicine, carboplatin and cyclophosphamide///molecule_ch1: total RNA///extract_protocol_ch1: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch1: Cy3///label_protocol_ch1: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch1: 9606///source_name_ch2: Universal Human Reference RNA purchased from Stratagene///organism_ch2: Homo sapiens///characteristics_ch2: Reference///molecule_ch2: total RNA///extract_protocol_ch2: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch2: Cy5///label_protocol_ch2: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch2: 9606///hyb_protocol: The probes were purified using ChipShot labelling cleanup system (Promega). The hybridizations were carried out using Pronto! Micro Array reagent systems (Corning Inc.). For each sample, labelled tumour cDNA and reference cDNA were co-precipitated and hybridised to the oligoarray slide.  After hybridization, slides were washed sequential.///scan_protocol: Scanned on an Agilent G2565AA scanner.///scan_protocol.1: Images were quantified using Genepix 6.0.0.74 (Axon Instruments).///description: Comparison of ovarian tumors of 5 year survivors to deceased patients///data_processing: Intensities were calculated by mean spot - median background. Flagged spots were removed as well as spots with intensities below 20 in both channels. Intensities below 20 in one channel were set to 20 to compensate for extreme quotients. Loess normalization was used///platform_id: GPL5886///contact_name: Karolina,,Partheen///contact_email: karolina.partheen@gu.se///contact_phone: +46+31 342 78 55///contact_fax: +46 +31 41 72 05///contact_department: department of Oncology///contact_institute: University of Gothenburg///contact_address: Bl Strket 2///contact_city: Gothenburg///contact_zip.postal_code: 413 45///contact_country: Sweden///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM311nnn/GSM311941/GSM311941.gpr.gz///data_row_count: 30000"
"GSM311942"	"76DC"	NA	"tumor"	"ser"	"ov"	NA	NA	"late"	3	"c"	NA	76	"y"	NA	NA	NA	NA	NA	NA	"short"	NA	NA	NA	"suboptimal"	NA	NA	NA	NA	"title: 76DC///geo_accession: GSM311942///status: Public on Aug 12 2008///submission_date: Aug 12 2008///last_update_date: Aug 13 2008///type: RNA///channel_count: 2///source_name_ch1: serous ovarian adenocarcinoma///organism_ch1: Homo sapiens///characteristics_ch1: fresh frozen tumour///characteristics_ch1.1: deceased///characteristics_ch1.2: stage IIIc///characteristics_ch1.3: macroscopic residual tumor///characteristics_ch1.4: age at diagnosis 76///characteristics_ch1.5: post surgical chemo therapy farmorubicine, carboplatin and cyclophosphamide///molecule_ch1: total RNA///extract_protocol_ch1: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch1: Cy3///label_protocol_ch1: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch1: 9606///source_name_ch2: Universal Human Reference RNA purchased from Stratagene///organism_ch2: Homo sapiens///characteristics_ch2: Reference///molecule_ch2: total RNA///extract_protocol_ch2: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch2: Cy5///label_protocol_ch2: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch2: 9606///hyb_protocol: The probes were purified using ChipShot labelling cleanup system (Promega). The hybridizations were carried out using Pronto! Micro Array reagent systems (Corning Inc.). For each sample, labelled tumour cDNA and reference cDNA were co-precipitated and hybridised to the oligoarray slide.  After hybridization, slides were washed sequential.///scan_protocol: Scanned on an Agilent G2565AA scanner.///scan_protocol.1: Images were quantified using Genepix 6.0.0.74 (Axon Instruments).///description: Comparison of ovarian tumors of 5 year survivors to deceased patients///data_processing: Intensities were calculated by mean spot - median background. Flagged spots were removed as well as spots with intensities below 20 in both channels. Intensities below 20 in one channel were set to 20 to compensate for extreme quotients. Loess normalization was used///platform_id: GPL5886///contact_name: Karolina,,Partheen///contact_email: karolina.partheen@gu.se///contact_phone: +46+31 342 78 55///contact_fax: +46 +31 41 72 05///contact_department: department of Oncology///contact_institute: University of Gothenburg///contact_address: Bl Strket 2///contact_city: Gothenburg///contact_zip.postal_code: 413 45///contact_country: Sweden///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM311nnn/GSM311942/GSM311942.gpr.gz///data_row_count: 30000"
"GSM311943"	"83LC"	NA	"tumor"	"ser"	"ov"	NA	NA	"late"	3	"c"	NA	58	"y"	NA	NA	NA	NA	NA	NA	"long"	NA	NA	NA	"suboptimal"	NA	NA	NA	NA	"title: 83LC///geo_accession: GSM311943///status: Public on Aug 12 2008///submission_date: Aug 12 2008///last_update_date: Aug 13 2008///type: RNA///channel_count: 2///source_name_ch1: serous ovarian adenocarcinoma///organism_ch1: Homo sapiens///characteristics_ch1: fresh frozen tumour///characteristics_ch1.1: 5 year survivor///characteristics_ch1.2: stage IIIc///characteristics_ch1.3: macroscopic residual tumor///characteristics_ch1.4: age at diagnosis 58///characteristics_ch1.5: post surgical chemo therapy farmorubicine, carboplatin and cyclophosphamide///molecule_ch1: total RNA///extract_protocol_ch1: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch1: Cy3///label_protocol_ch1: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch1: 9606///source_name_ch2: Universal Human Reference RNA purchased from Stratagene///organism_ch2: Homo sapiens///characteristics_ch2: Reference///molecule_ch2: total RNA///extract_protocol_ch2: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch2: Cy5///label_protocol_ch2: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch2: 9606///hyb_protocol: The probes were purified using ChipShot labelling cleanup system (Promega). The hybridizations were carried out using Pronto! Micro Array reagent systems (Corning Inc.). For each sample, labelled tumour cDNA and reference cDNA were co-precipitated and hybridised to the oligoarray slide.  After hybridization, slides were washed sequential.///scan_protocol: Scanned on an Agilent G2565AA scanner.///scan_protocol.1: Images were quantified using Genepix 6.0.0.74 (Axon Instruments).///description: Comparison of ovarian tumors of 5 year survivors to deceased patients///data_processing: Intensities were calculated by mean spot - median background. Flagged spots were removed as well as spots with intensities below 20 in both channels. Intensities below 20 in one channel were set to 20 to compensate for extreme quotients. Loess normalization was used///platform_id: GPL5886///contact_name: Karolina,,Partheen///contact_email: karolina.partheen@gu.se///contact_phone: +46+31 342 78 55///contact_fax: +46 +31 41 72 05///contact_department: department of Oncology///contact_institute: University of Gothenburg///contact_address: Bl Strket 2///contact_city: Gothenburg///contact_zip.postal_code: 413 45///contact_country: Sweden///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM311nnn/GSM311943/GSM311943.gpr.gz///data_row_count: 30000"
"GSM311944"	"99LC0"	NA	"tumor"	"ser"	"ov"	NA	NA	"late"	3	"c"	NA	72	"y"	NA	NA	NA	NA	NA	NA	"long"	NA	NA	NA	"optimal"	NA	NA	NA	NA	"title: 99LC0///geo_accession: GSM311944///status: Public on Aug 12 2008///submission_date: Aug 12 2008///last_update_date: Aug 13 2008///type: RNA///channel_count: 2///source_name_ch1: serous ovarian adenocarcinoma///organism_ch1: Homo sapiens///characteristics_ch1: fresh frozen tumour///characteristics_ch1.1: 5 year survivor///characteristics_ch1.2: stage IIIc///characteristics_ch1.3: no macroscopic residual tumor///characteristics_ch1.4: age at diagnosis 72///characteristics_ch1.5: post surgical chemo therapy farmorubicine, carboplatin and cyclophosphamide///molecule_ch1: total RNA///extract_protocol_ch1: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch1: Cy3///label_protocol_ch1: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch1: 9606///source_name_ch2: Universal Human Reference RNA purchased from Stratagene///organism_ch2: Homo sapiens///characteristics_ch2: Reference///molecule_ch2: total RNA///extract_protocol_ch2: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch2: Cy5///label_protocol_ch2: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch2: 9606///hyb_protocol: The probes were purified using ChipShot labelling cleanup system (Promega). The hybridizations were carried out using Pronto! Micro Array reagent systems (Corning Inc.). For each sample, labelled tumour cDNA and reference cDNA were co-precipitated and hybridised to the oligoarray slide.  After hybridization, slides were washed sequential.///scan_protocol: Scanned on an Agilent G2565AA scanner.///scan_protocol.1: Images were quantified using Genepix 6.0.0.74 (Axon Instruments).///description: Comparison of ovarian tumors of 5 year survivors to deceased patients///data_processing: Intensities were calculated by mean spot - median background. Flagged spots were removed as well as spots with intensities below 20 in both channels. Intensities below 20 in one channel were set to 20 to compensate for extreme quotients. Loess normalization was used///platform_id: GPL5886///contact_name: Karolina,,Partheen///contact_email: karolina.partheen@gu.se///contact_phone: +46+31 342 78 55///contact_fax: +46 +31 41 72 05///contact_department: department of Oncology///contact_institute: University of Gothenburg///contact_address: Bl Strket 2///contact_city: Gothenburg///contact_zip.postal_code: 413 45///contact_country: Sweden///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM311nnn/GSM311944/GSM311944.gpr.gz///data_row_count: 30000"
"GSM311945"	"123DC"	NA	"tumor"	"ser"	"ov"	NA	NA	"late"	3	"c"	NA	56	"y"	NA	NA	NA	NA	NA	NA	"short"	NA	NA	NA	"suboptimal"	NA	NA	NA	NA	"title: 123DC///geo_accession: GSM311945///status: Public on Aug 12 2008///submission_date: Aug 12 2008///last_update_date: Aug 13 2008///type: RNA///channel_count: 2///source_name_ch1: serous ovarian adenocarcinoma///organism_ch1: Homo sapiens///characteristics_ch1: fresh frozen tumour///characteristics_ch1.1: deceased///characteristics_ch1.2: stage IIIc///characteristics_ch1.3: macroscopic residual tumor///characteristics_ch1.4: age at diagnosis 56///characteristics_ch1.5: post surgical chemo therapy farmorubicine, carboplatin and cyclophosphamide///molecule_ch1: total RNA///extract_protocol_ch1: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch1: Cy3///label_protocol_ch1: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch1: 9606///source_name_ch2: Universal Human Reference RNA purchased from Stratagene///organism_ch2: Homo sapiens///characteristics_ch2: Reference///molecule_ch2: total RNA///extract_protocol_ch2: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch2: Cy5///label_protocol_ch2: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch2: 9606///hyb_protocol: The probes were purified using ChipShot labelling cleanup system (Promega). The hybridizations were carried out using Pronto! Micro Array reagent systems (Corning Inc.). For each sample, labelled tumour cDNA and reference cDNA were co-precipitated and hybridised to the oligoarray slide.  After hybridization, slides were washed sequential.///scan_protocol: Scanned on an Agilent G2565AA scanner.///scan_protocol.1: Images were quantified using Genepix 6.0.0.74 (Axon Instruments).///description: Comparison of ovarian tumors of 5 year survivors to deceased patients///data_processing: Intensities were calculated by mean spot - median background. Flagged spots were removed as well as spots with intensities below 20 in both channels. Intensities below 20 in one channel were set to 20 to compensate for extreme quotients. Loess normalization was used///platform_id: GPL5886///contact_name: Karolina,,Partheen///contact_email: karolina.partheen@gu.se///contact_phone: +46+31 342 78 55///contact_fax: +46 +31 41 72 05///contact_department: department of Oncology///contact_institute: University of Gothenburg///contact_address: Bl Strket 2///contact_city: Gothenburg///contact_zip.postal_code: 413 45///contact_country: Sweden///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM311nnn/GSM311945/GSM311945.gpr.gz///data_row_count: 30000"
"GSM311946"	"134LC"	NA	"tumor"	"ser"	"ov"	NA	NA	"late"	3	"c"	NA	60	"y"	NA	NA	NA	NA	NA	NA	"long"	NA	NA	NA	"suboptimal"	NA	NA	NA	NA	"title: 134LC///geo_accession: GSM311946///status: Public on Aug 12 2008///submission_date: Aug 12 2008///last_update_date: Aug 13 2008///type: RNA///channel_count: 2///source_name_ch1: serous ovarian adenocarcinoma///organism_ch1: Homo sapiens///characteristics_ch1: fresh frozen tumour///characteristics_ch1.1: 5 year survivor///characteristics_ch1.2: stage IIIc///characteristics_ch1.3: macroscopic residual tumor///characteristics_ch1.4: age at diagnosis 60///characteristics_ch1.5: post surgical chemo therapy farmorubicine, carboplatin and cyclophosphamide///molecule_ch1: total RNA///extract_protocol_ch1: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch1: Cy3///label_protocol_ch1: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch1: 9606///source_name_ch2: Universal Human Reference RNA purchased from Stratagene///organism_ch2: Homo sapiens///characteristics_ch2: Reference///molecule_ch2: total RNA///extract_protocol_ch2: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch2: Cy5///label_protocol_ch2: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch2: 9606///hyb_protocol: The probes were purified using ChipShot labelling cleanup system (Promega). The hybridizations were carried out using Pronto! Micro Array reagent systems (Corning Inc.). For each sample, labelled tumour cDNA and reference cDNA were co-precipitated and hybridised to the oligoarray slide.  After hybridization, slides were washed sequential.///scan_protocol: Scanned on an Agilent G2565AA scanner.///scan_protocol.1: Images were quantified using Genepix 6.0.0.74 (Axon Instruments).///description: Comparison of ovarian tumors of 5 year survivors to deceased patients///data_processing: Intensities were calculated by mean spot - median background. Flagged spots were removed as well as spots with intensities below 20 in both channels. Intensities below 20 in one channel were set to 20 to compensate for extreme quotients. Loess normalization was used///platform_id: GPL5886///contact_name: Karolina,,Partheen///contact_email: karolina.partheen@gu.se///contact_phone: +46+31 342 78 55///contact_fax: +46 +31 41 72 05///contact_department: department of Oncology///contact_institute: University of Gothenburg///contact_address: Bl Strket 2///contact_city: Gothenburg///contact_zip.postal_code: 413 45///contact_country: Sweden///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM311nnn/GSM311946/GSM311946.gpr.gz///data_row_count: 30000"
"GSM311947"	"164DC"	NA	"tumor"	"ser"	"ov"	NA	NA	"late"	3	"c"	NA	73	"y"	NA	NA	NA	NA	NA	NA	"short"	NA	NA	NA	"suboptimal"	NA	NA	NA	NA	"title: 164DC///geo_accession: GSM311947///status: Public on Aug 12 2008///submission_date: Aug 12 2008///last_update_date: Aug 13 2008///type: RNA///channel_count: 2///source_name_ch1: serous ovarian adenocarcinoma///organism_ch1: Homo sapiens///characteristics_ch1: fresh frozen tumour///characteristics_ch1.1: deceased///characteristics_ch1.2: stage IIIc///characteristics_ch1.3: macroscopic residual tumor///characteristics_ch1.4: age at diagnosis 73///characteristics_ch1.5: post surgical chemo therapy farmorubicine, carboplatin and cyclophosphamide///molecule_ch1: total RNA///extract_protocol_ch1: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch1: Cy3///label_protocol_ch1: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch1: 9606///source_name_ch2: Universal Human Reference RNA purchased from Stratagene///organism_ch2: Homo sapiens///characteristics_ch2: Reference///molecule_ch2: total RNA///extract_protocol_ch2: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch2: Cy5///label_protocol_ch2: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch2: 9606///hyb_protocol: The probes were purified using ChipShot labelling cleanup system (Promega). The hybridizations were carried out using Pronto! Micro Array reagent systems (Corning Inc.). For each sample, labelled tumour cDNA and reference cDNA were co-precipitated and hybridised to the oligoarray slide.  After hybridization, slides were washed sequential.///scan_protocol: Scanned on an Agilent G2565AA scanner.///scan_protocol.1: Images were quantified using Genepix 6.0.0.74 (Axon Instruments).///description: Comparison of ovarian tumors of 5 year survivors to deceased patients///data_processing: Intensities were calculated by mean spot - median background. Flagged spots were removed as well as spots with intensities below 20 in both channels. Intensities below 20 in one channel were set to 20 to compensate for extreme quotients. Loess normalization was used///platform_id: GPL5886///contact_name: Karolina,,Partheen///contact_email: karolina.partheen@gu.se///contact_phone: +46+31 342 78 55///contact_fax: +46 +31 41 72 05///contact_department: department of Oncology///contact_institute: University of Gothenburg///contact_address: Bl Strket 2///contact_city: Gothenburg///contact_zip.postal_code: 413 45///contact_country: Sweden///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM311nnn/GSM311947/GSM311947.gpr.gz///data_row_count: 30000"
"GSM311948"	"193DC"	NA	"tumor"	"ser"	"ov"	NA	NA	"late"	3	"c"	NA	59	"y"	NA	NA	NA	NA	NA	NA	"short"	NA	NA	NA	"suboptimal"	NA	NA	NA	NA	"title: 193DC///geo_accession: GSM311948///status: Public on Aug 12 2008///submission_date: Aug 12 2008///last_update_date: Aug 13 2008///type: RNA///channel_count: 2///source_name_ch1: serous ovarian adenocarcinoma///organism_ch1: Homo sapiens///characteristics_ch1: fresh frozen tumour///characteristics_ch1.1: deceased///characteristics_ch1.2: stage IIIc///characteristics_ch1.3: macroscopic residual tumor///characteristics_ch1.4: age at diagnosis 59///characteristics_ch1.5: post surgical chemo therapy farmorubicine, carboplatin and cyclophosphamide///molecule_ch1: total RNA///extract_protocol_ch1: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch1: Cy3///label_protocol_ch1: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch1: 9606///source_name_ch2: Universal Human Reference RNA purchased from Stratagene///organism_ch2: Homo sapiens///characteristics_ch2: Reference///molecule_ch2: total RNA///extract_protocol_ch2: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch2: Cy5///label_protocol_ch2: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch2: 9606///hyb_protocol: The probes were purified using ChipShot labelling cleanup system (Promega). The hybridizations were carried out using Pronto! Micro Array reagent systems (Corning Inc.). For each sample, labelled tumour cDNA and reference cDNA were co-precipitated and hybridised to the oligoarray slide.  After hybridization, slides were washed sequential.///scan_protocol: Scanned on an Agilent G2565AA scanner.///scan_protocol.1: Images were quantified using Genepix 6.0.0.74 (Axon Instruments).///description: Comparison of ovarian tumors of 5 year survivors to deceased patients///data_processing: Intensities were calculated by mean spot - median background. Flagged spots were removed as well as spots with intensities below 20 in both channels. Intensities below 20 in one channel were set to 20 to compensate for extreme quotients. Loess normalization was used///platform_id: GPL5886///contact_name: Karolina,,Partheen///contact_email: karolina.partheen@gu.se///contact_phone: +46+31 342 78 55///contact_fax: +46 +31 41 72 05///contact_department: department of Oncology///contact_institute: University of Gothenburg///contact_address: Bl Strket 2///contact_city: Gothenburg///contact_zip.postal_code: 413 45///contact_country: Sweden///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM311nnn/GSM311948/GSM311948.gpr.gz///data_row_count: 30000"
"GSM311949"	"198DC"	NA	"tumor"	"ser"	"ov"	NA	NA	"late"	3	"c"	NA	67	"y"	NA	NA	NA	NA	NA	NA	"short"	NA	NA	NA	"suboptimal"	NA	NA	NA	NA	"title: 198DC///geo_accession: GSM311949///status: Public on Aug 12 2008///submission_date: Aug 12 2008///last_update_date: Aug 13 2008///type: RNA///channel_count: 2///source_name_ch1: serous ovarian adenocarcinoma///organism_ch1: Homo sapiens///characteristics_ch1: fresh frozen tumour///characteristics_ch1.1: deceased///characteristics_ch1.2: stage IIIc///characteristics_ch1.3: macroscopic residual tumor///characteristics_ch1.4: age at diagnosis 67///characteristics_ch1.5: post surgical chemo therapy farmorubicine, carboplatin and cyclophosphamide///molecule_ch1: total RNA///extract_protocol_ch1: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch1: Cy3///label_protocol_ch1: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch1: 9606///source_name_ch2: Universal Human Reference RNA purchased from Stratagene///organism_ch2: Homo sapiens///characteristics_ch2: Reference///molecule_ch2: total RNA///extract_protocol_ch2: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch2: Cy5///label_protocol_ch2: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch2: 9606///hyb_protocol: The probes were purified using ChipShot labelling cleanup system (Promega). The hybridizations were carried out using Pronto! Micro Array reagent systems (Corning Inc.). For each sample, labelled tumour cDNA and reference cDNA were co-precipitated and hybridised to the oligoarray slide.  After hybridization, slides were washed sequential.///scan_protocol: Scanned on an Agilent G2565AA scanner.///scan_protocol.1: Images were quantified using Genepix 6.0.0.74 (Axon Instruments).///description: Comparison of ovarian tumors of 5 year survivors to deceased patients///data_processing: Intensities were calculated by mean spot - median background. Flagged spots were removed as well as spots with intensities below 20 in both channels. Intensities below 20 in one channel were set to 20 to compensate for extreme quotients. Loess normalization was used///platform_id: GPL5886///contact_name: Karolina,,Partheen///contact_email: karolina.partheen@gu.se///contact_phone: +46+31 342 78 55///contact_fax: +46 +31 41 72 05///contact_department: department of Oncology///contact_institute: University of Gothenburg///contact_address: Bl Strket 2///contact_city: Gothenburg///contact_zip.postal_code: 413 45///contact_country: Sweden///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM311nnn/GSM311949/GSM311949.gpr.gz///data_row_count: 30000"
"GSM311950"	"202DC"	NA	"tumor"	"ser"	"ov"	NA	NA	"late"	3	"c"	NA	59	"y"	NA	NA	NA	NA	NA	NA	"short"	NA	NA	NA	"suboptimal"	NA	NA	NA	NA	"title: 202DC///geo_accession: GSM311950///status: Public on Aug 12 2008///submission_date: Aug 12 2008///last_update_date: Aug 13 2008///type: RNA///channel_count: 2///source_name_ch1: serous ovarian adenocarcinoma///organism_ch1: Homo sapiens///characteristics_ch1: fresh frozen tumour///characteristics_ch1.1: deceased///characteristics_ch1.2: stage IIIc///characteristics_ch1.3: macroscopic residual tumor///characteristics_ch1.4: age at diagnosis 59///characteristics_ch1.5: post surgical chemo therapy farmorubicine, carboplatin and cyclophosphamide///molecule_ch1: total RNA///extract_protocol_ch1: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch1: Cy3///label_protocol_ch1: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch1: 9606///source_name_ch2: Universal Human Reference RNA purchased from Stratagene///organism_ch2: Homo sapiens///characteristics_ch2: Reference///molecule_ch2: total RNA///extract_protocol_ch2: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch2: Cy5///label_protocol_ch2: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch2: 9606///hyb_protocol: The probes were purified using ChipShot labelling cleanup system (Promega). The hybridizations were carried out using Pronto! Micro Array reagent systems (Corning Inc.). For each sample, labelled tumour cDNA and reference cDNA were co-precipitated and hybridised to the oligoarray slide.  After hybridization, slides were washed sequential.///scan_protocol: Scanned on an Agilent G2565AA scanner.///scan_protocol.1: Images were quantified using Genepix 6.0.0.74 (Axon Instruments).///description: Comparison of ovarian tumors of 5 year survivors to deceased patients///data_processing: Intensities were calculated by mean spot - median background. Flagged spots were removed as well as spots with intensities below 20 in both channels. Intensities below 20 in one channel were set to 20 to compensate for extreme quotients. Loess normalization was used///platform_id: GPL5886///contact_name: Karolina,,Partheen///contact_email: karolina.partheen@gu.se///contact_phone: +46+31 342 78 55///contact_fax: +46 +31 41 72 05///contact_department: department of Oncology///contact_institute: University of Gothenburg///contact_address: Bl Strket 2///contact_city: Gothenburg///contact_zip.postal_code: 413 45///contact_country: Sweden///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM311nnn/GSM311950/GSM311950.gpr.gz///data_row_count: 30000"
"GSM311951"	"211DC"	NA	"tumor"	"ser"	"ov"	NA	NA	"late"	3	"c"	NA	70	"y"	NA	NA	NA	NA	NA	NA	"short"	NA	NA	NA	"suboptimal"	NA	NA	NA	NA	"title: 211DC///geo_accession: GSM311951///status: Public on Aug 12 2008///submission_date: Aug 12 2008///last_update_date: Aug 13 2008///type: RNA///channel_count: 2///source_name_ch1: serous ovarian adenocarcinoma///organism_ch1: Homo sapiens///characteristics_ch1: fresh frozen tumour///characteristics_ch1.1: deceased///characteristics_ch1.2: stage IIIc///characteristics_ch1.3: macroscopic residual tumor///characteristics_ch1.4: age at diagnosis 70///characteristics_ch1.5: post surgical chemo therapy farmorubicine, carboplatin and cyclophosphamide///molecule_ch1: total RNA///extract_protocol_ch1: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch1: Cy3///label_protocol_ch1: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch1: 9606///source_name_ch2: Universal Human Reference RNA purchased from Stratagene///organism_ch2: Homo sapiens///characteristics_ch2: Reference///molecule_ch2: total RNA///extract_protocol_ch2: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch2: Cy5///label_protocol_ch2: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch2: 9606///hyb_protocol: The probes were purified using ChipShot labelling cleanup system (Promega). The hybridizations were carried out using Pronto! Micro Array reagent systems (Corning Inc.). For each sample, labelled tumour cDNA and reference cDNA were co-precipitated and hybridised to the oligoarray slide.  After hybridization, slides were washed sequential.///scan_protocol: Scanned on an Agilent G2565AA scanner.///scan_protocol.1: Images were quantified using Genepix 6.0.0.74 (Axon Instruments).///description: Comparison of ovarian tumors of 5 year survivors to deceased patients///data_processing: Intensities were calculated by mean spot - median background. Flagged spots were removed as well as spots with intensities below 20 in both channels. Intensities below 20 in one channel were set to 20 to compensate for extreme quotients. Loess normalization was used///platform_id: GPL5886///contact_name: Karolina,,Partheen///contact_email: karolina.partheen@gu.se///contact_phone: +46+31 342 78 55///contact_fax: +46 +31 41 72 05///contact_department: department of Oncology///contact_institute: University of Gothenburg///contact_address: Bl Strket 2///contact_city: Gothenburg///contact_zip.postal_code: 413 45///contact_country: Sweden///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM311nnn/GSM311951/GSM311951.gpr.gz///data_row_count: 30000"
"GSM311952"	"272DC"	NA	"tumor"	"ser"	"ov"	NA	NA	"late"	3	"c"	NA	54	"y"	NA	NA	NA	NA	NA	NA	"short"	NA	NA	NA	"suboptimal"	NA	NA	NA	NA	"title: 272DC///geo_accession: GSM311952///status: Public on Aug 12 2008///submission_date: Aug 12 2008///last_update_date: Aug 13 2008///type: RNA///channel_count: 2///source_name_ch1: serous ovarian adenocarcinoma///organism_ch1: Homo sapiens///characteristics_ch1: fresh frozen tumour///characteristics_ch1.1: deceased///characteristics_ch1.2: stage IIIc///characteristics_ch1.3: macroscopic residual tumor///characteristics_ch1.4: age at diagnosis 54///characteristics_ch1.5: post surgical chemo therapy farmorubicine, carboplatin and cyclophosphamide///molecule_ch1: total RNA///extract_protocol_ch1: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch1: Cy3///label_protocol_ch1: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch1: 9606///source_name_ch2: Universal Human Reference RNA purchased from Stratagene///organism_ch2: Homo sapiens///characteristics_ch2: Reference///molecule_ch2: total RNA///extract_protocol_ch2: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch2: Cy5///label_protocol_ch2: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch2: 9606///hyb_protocol: The probes were purified using ChipShot labelling cleanup system (Promega). The hybridizations were carried out using Pronto! Micro Array reagent systems (Corning Inc.). For each sample, labelled tumour cDNA and reference cDNA were co-precipitated and hybridised to the oligoarray slide.  After hybridization, slides were washed sequential.///scan_protocol: Scanned on an Agilent G2565AA scanner.///scan_protocol.1: Images were quantified using Genepix 6.0.0.74 (Axon Instruments).///description: Comparison of ovarian tumors of 5 year survivors to deceased patients///data_processing: Intensities were calculated by mean spot - median background. Flagged spots were removed as well as spots with intensities below 20 in both channels. Intensities below 20 in one channel were set to 20 to compensate for extreme quotients. Loess normalization was used///platform_id: GPL5886///contact_name: Karolina,,Partheen///contact_email: karolina.partheen@gu.se///contact_phone: +46+31 342 78 55///contact_fax: +46 +31 41 72 05///contact_department: department of Oncology///contact_institute: University of Gothenburg///contact_address: Bl Strket 2///contact_city: Gothenburg///contact_zip.postal_code: 413 45///contact_country: Sweden///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM311nnn/GSM311952/GSM311952.gpr.gz///data_row_count: 30000"
"GSM311953"	"405LB"	NA	"tumor"	"ser"	"ov"	NA	NA	"late"	3	"b"	NA	50	"y"	NA	NA	NA	NA	NA	NA	"long"	NA	NA	NA	"suboptimal"	NA	NA	NA	NA	"title: 405LB///geo_accession: GSM311953///status: Public on Aug 12 2008///submission_date: Aug 12 2008///last_update_date: Aug 13 2008///type: RNA///channel_count: 2///source_name_ch1: serous ovarian adenocarcinoma///organism_ch1: Homo sapiens///characteristics_ch1: fresh frozen tumour///characteristics_ch1.1: 5 year survivor///characteristics_ch1.2: stage IIIab///characteristics_ch1.3: macroscopic residual tumor///characteristics_ch1.4: age at diagnosis 50///characteristics_ch1.5: post surgical chemo therapy farmorubicine, carboplatin and cyclophosphamide///molecule_ch1: total RNA///extract_protocol_ch1: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch1: Cy3///label_protocol_ch1: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch1: 9606///source_name_ch2: Universal Human Reference RNA purchased from Stratagene///organism_ch2: Homo sapiens///characteristics_ch2: Reference///molecule_ch2: total RNA///extract_protocol_ch2: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch2: Cy5///label_protocol_ch2: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch2: 9606///hyb_protocol: The probes were purified using ChipShot labelling cleanup system (Promega). The hybridizations were carried out using Pronto! Micro Array reagent systems (Corning Inc.). For each sample, labelled tumour cDNA and reference cDNA were co-precipitated and hybridised to the oligoarray slide.  After hybridization, slides were washed sequential.///scan_protocol: Scanned on an Agilent G2565AA scanner.///scan_protocol.1: Images were quantified using Genepix 6.0.0.74 (Axon Instruments).///description: Comparison of ovarian tumors of 5 year survivors to deceased patients///data_processing: Intensities were calculated by mean spot - median background. Flagged spots were removed as well as spots with intensities below 20 in both channels. Intensities below 20 in one channel were set to 20 to compensate for extreme quotients. Loess normalization was used///platform_id: GPL5886///contact_name: Karolina,,Partheen///contact_email: karolina.partheen@gu.se///contact_phone: +46+31 342 78 55///contact_fax: +46 +31 41 72 05///contact_department: department of Oncology///contact_institute: University of Gothenburg///contact_address: Bl Strket 2///contact_city: Gothenburg///contact_zip.postal_code: 413 45///contact_country: Sweden///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM311nnn/GSM311953/GSM311953.gpr.gz///data_row_count: 30000"
"GSM311954"	"436DC"	NA	"tumor"	"ser"	"ov"	NA	NA	"late"	3	"c"	NA	56	"y"	NA	NA	NA	NA	NA	NA	"short"	NA	NA	NA	"suboptimal"	NA	NA	NA	NA	"title: 436DC///geo_accession: GSM311954///status: Public on Aug 12 2008///submission_date: Aug 12 2008///last_update_date: Aug 13 2008///type: RNA///channel_count: 2///source_name_ch1: serous ovarian adenocarcinoma///organism_ch1: Homo sapiens///characteristics_ch1: fresh frozen tumour///characteristics_ch1.1: deceased///characteristics_ch1.2: stage IIIc///characteristics_ch1.3: macroscopic residual tumor///characteristics_ch1.4: age at diagnosis 56///characteristics_ch1.5: post surgical chemo therapy farmorubicine, carboplatin and cyclophosphamide///molecule_ch1: total RNA///extract_protocol_ch1: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch1: Cy3///label_protocol_ch1: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch1: 9606///source_name_ch2: Universal Human Reference RNA purchased from Stratagene///organism_ch2: Homo sapiens///characteristics_ch2: Reference///molecule_ch2: total RNA///extract_protocol_ch2: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch2: Cy5///label_protocol_ch2: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch2: 9606///hyb_protocol: The probes were purified using ChipShot labelling cleanup system (Promega). The hybridizations were carried out using Pronto! Micro Array reagent systems (Corning Inc.). For each sample, labelled tumour cDNA and reference cDNA were co-precipitated and hybridised to the oligoarray slide.  After hybridization, slides were washed sequential.///scan_protocol: Scanned on an Agilent G2565AA scanner.///scan_protocol.1: Images were quantified using Genepix 6.0.0.74 (Axon Instruments).///description: Comparison of ovarian tumors of 5 year survivors to deceased patients///data_processing: Intensities were calculated by mean spot - median background. Flagged spots were removed as well as spots with intensities below 20 in both channels. Intensities below 20 in one channel were set to 20 to compensate for extreme quotients. Loess normalization was used///platform_id: GPL5886///contact_name: Karolina,,Partheen///contact_email: karolina.partheen@gu.se///contact_phone: +46+31 342 78 55///contact_fax: +46 +31 41 72 05///contact_department: department of Oncology///contact_institute: University of Gothenburg///contact_address: Bl Strket 2///contact_city: Gothenburg///contact_zip.postal_code: 413 45///contact_country: Sweden///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM311nnn/GSM311954/GSM311954.gpr.gz///data_row_count: 30000"
"GSM311955"	"452DC"	NA	"tumor"	"ser"	"ov"	NA	NA	"late"	3	"c"	NA	69	"y"	NA	NA	NA	NA	NA	NA	"short"	NA	NA	NA	"suboptimal"	NA	NA	NA	NA	"title: 452DC///geo_accession: GSM311955///status: Public on Aug 12 2008///submission_date: Aug 12 2008///last_update_date: Aug 13 2008///type: RNA///channel_count: 2///source_name_ch1: serous ovarian adenocarcinoma///organism_ch1: Homo sapiens///characteristics_ch1: fresh frozen tumour///characteristics_ch1.1: deceased///characteristics_ch1.2: stage IIIc///characteristics_ch1.3: macroscopic residual tumor///characteristics_ch1.4: age at diagnosis 69///characteristics_ch1.5: post surgical chemo therapy farmorubicine, carboplatin and cyclophosphamide///molecule_ch1: total RNA///extract_protocol_ch1: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch1: Cy3///label_protocol_ch1: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch1: 9606///source_name_ch2: Universal Human Reference RNA purchased from Stratagene///organism_ch2: Homo sapiens///characteristics_ch2: Reference///molecule_ch2: total RNA///extract_protocol_ch2: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch2: Cy5///label_protocol_ch2: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch2: 9606///hyb_protocol: The probes were purified using ChipShot labelling cleanup system (Promega). The hybridizations were carried out using Pronto! Micro Array reagent systems (Corning Inc.). For each sample, labelled tumour cDNA and reference cDNA were co-precipitated and hybridised to the oligoarray slide.  After hybridization, slides were washed sequential.///scan_protocol: Scanned on an Agilent G2565AA scanner.///scan_protocol.1: Images were quantified using Genepix 6.0.0.74 (Axon Instruments).///description: Comparison of ovarian tumors of 5 year survivors to deceased patients///data_processing: Intensities were calculated by mean spot - median background. Flagged spots were removed as well as spots with intensities below 20 in both channels. Intensities below 20 in one channel were set to 20 to compensate for extreme quotients. Loess normalization was used///platform_id: GPL5886///contact_name: Karolina,,Partheen///contact_email: karolina.partheen@gu.se///contact_phone: +46+31 342 78 55///contact_fax: +46 +31 41 72 05///contact_department: department of Oncology///contact_institute: University of Gothenburg///contact_address: Bl Strket 2///contact_city: Gothenburg///contact_zip.postal_code: 413 45///contact_country: Sweden///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM311nnn/GSM311955/GSM311955.gpr.gz///data_row_count: 30000"
"GSM311956"	"454LC"	NA	"tumor"	"ser"	"ov"	NA	NA	"late"	3	"c"	NA	43	"y"	NA	NA	NA	NA	NA	NA	"long"	NA	NA	NA	"suboptimal"	NA	NA	NA	NA	"title: 454LC///geo_accession: GSM311956///status: Public on Aug 12 2008///submission_date: Aug 12 2008///last_update_date: Aug 13 2008///type: RNA///channel_count: 2///source_name_ch1: serous ovarian adenocarcinoma///organism_ch1: Homo sapiens///characteristics_ch1: fresh frozen tumour///characteristics_ch1.1: 5 year survivor///characteristics_ch1.2: stage IIIc///characteristics_ch1.3: macroscopic residual tumor///characteristics_ch1.4: age at diagnosis 43///characteristics_ch1.5: post surgical chemo therapy farmorubicine, carboplatin and cyclophosphamide///molecule_ch1: total RNA///extract_protocol_ch1: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch1: Cy3///label_protocol_ch1: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch1: 9606///source_name_ch2: Universal Human Reference RNA purchased from Stratagene///organism_ch2: Homo sapiens///characteristics_ch2: Reference///molecule_ch2: total RNA///extract_protocol_ch2: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch2: Cy5///label_protocol_ch2: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch2: 9606///hyb_protocol: The probes were purified using ChipShot labelling cleanup system (Promega). The hybridizations were carried out using Pronto! Micro Array reagent systems (Corning Inc.). For each sample, labelled tumour cDNA and reference cDNA were co-precipitated and hybridised to the oligoarray slide.  After hybridization, slides were washed sequential.///scan_protocol: Scanned on an Agilent G2565AA scanner.///scan_protocol.1: Images were quantified using Genepix 6.0.0.74 (Axon Instruments).///description: Comparison of ovarian tumors of 5 year survivors to deceased patients///data_processing: Intensities were calculated by mean spot - median background. Flagged spots were removed as well as spots with intensities below 20 in both channels. Intensities below 20 in one channel were set to 20 to compensate for extreme quotients. Loess normalization was used///platform_id: GPL5886///contact_name: Karolina,,Partheen///contact_email: karolina.partheen@gu.se///contact_phone: +46+31 342 78 55///contact_fax: +46 +31 41 72 05///contact_department: department of Oncology///contact_institute: University of Gothenburg///contact_address: Bl Strket 2///contact_city: Gothenburg///contact_zip.postal_code: 413 45///contact_country: Sweden///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM311nnn/GSM311956/GSM311956.gpr.gz///data_row_count: 30000"
"GSM311957"	"462DB"	NA	"tumor"	"ser"	"ov"	NA	NA	"late"	3	"b"	NA	59	"y"	NA	NA	NA	NA	NA	NA	"short"	NA	NA	NA	"suboptimal"	NA	NA	NA	NA	"title: 462DB///geo_accession: GSM311957///status: Public on Aug 12 2008///submission_date: Aug 12 2008///last_update_date: Aug 13 2008///type: RNA///channel_count: 2///source_name_ch1: serous ovarian adenocarcinoma///organism_ch1: Homo sapiens///characteristics_ch1: fresh frozen tumour///characteristics_ch1.1: deceased///characteristics_ch1.2: stage IIIab///characteristics_ch1.3: macroscopic residual tumor///characteristics_ch1.4: age at diagnosis 59///characteristics_ch1.5: post surgical chemo therapy farmorubicine, carboplatin and cyclophosphamide///molecule_ch1: total RNA///extract_protocol_ch1: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch1: Cy3///label_protocol_ch1: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch1: 9606///source_name_ch2: Universal Human Reference RNA purchased from Stratagene///organism_ch2: Homo sapiens///characteristics_ch2: Reference///molecule_ch2: total RNA///extract_protocol_ch2: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch2: Cy5///label_protocol_ch2: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch2: 9606///hyb_protocol: The probes were purified using ChipShot labelling cleanup system (Promega). The hybridizations were carried out using Pronto! Micro Array reagent systems (Corning Inc.). For each sample, labelled tumour cDNA and reference cDNA were co-precipitated and hybridised to the oligoarray slide.  After hybridization, slides were washed sequential.///scan_protocol: Scanned on an Agilent G2565AA scanner.///scan_protocol.1: Images were quantified using Genepix 6.0.0.74 (Axon Instruments).///description: Comparison of ovarian tumors of 5 year survivors to deceased patients///data_processing: Intensities were calculated by mean spot - median background. Flagged spots were removed as well as spots with intensities below 20 in both channels. Intensities below 20 in one channel were set to 20 to compensate for extreme quotients. Loess normalization was used///platform_id: GPL5886///contact_name: Karolina,,Partheen///contact_email: karolina.partheen@gu.se///contact_phone: +46+31 342 78 55///contact_fax: +46 +31 41 72 05///contact_department: department of Oncology///contact_institute: University of Gothenburg///contact_address: Bl Strket 2///contact_city: Gothenburg///contact_zip.postal_code: 413 45///contact_country: Sweden///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM311nnn/GSM311957/GSM311957.gpr.gz///data_row_count: 30000"
"GSM311958"	"480DC0"	NA	"tumor"	"ser"	"ov"	NA	NA	"late"	3	"c"	NA	73	"y"	NA	NA	NA	NA	NA	NA	"short"	NA	NA	NA	"optimal"	NA	NA	NA	NA	"title: 480DC0///geo_accession: GSM311958///status: Public on Aug 12 2008///submission_date: Aug 12 2008///last_update_date: Aug 13 2008///type: RNA///channel_count: 2///source_name_ch1: serous ovarian adenocarcinoma///organism_ch1: Homo sapiens///characteristics_ch1: fresh frozen tumour///characteristics_ch1.1: deceased///characteristics_ch1.2: stage IIIc///characteristics_ch1.3: no macroscopic residual tumor///characteristics_ch1.4: age at diagnosis 73///characteristics_ch1.5: post surgical chemo therapy farmorubicine, carboplatin and cyclophosphamide///molecule_ch1: total RNA///extract_protocol_ch1: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch1: Cy3///label_protocol_ch1: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch1: 9606///source_name_ch2: Universal Human Reference RNA purchased from Stratagene///organism_ch2: Homo sapiens///characteristics_ch2: Reference///molecule_ch2: total RNA///extract_protocol_ch2: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch2: Cy5///label_protocol_ch2: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch2: 9606///hyb_protocol: The probes were purified using ChipShot labelling cleanup system (Promega). The hybridizations were carried out using Pronto! Micro Array reagent systems (Corning Inc.). For each sample, labelled tumour cDNA and reference cDNA were co-precipitated and hybridised to the oligoarray slide.  After hybridization, slides were washed sequential.///scan_protocol: Scanned on an Agilent G2565AA scanner.///scan_protocol.1: Images were quantified using Genepix 6.0.0.74 (Axon Instruments).///description: Comparison of ovarian tumors of 5 year survivors to deceased patients///data_processing: Intensities were calculated by mean spot - median background. Flagged spots were removed as well as spots with intensities below 20 in both channels. Intensities below 20 in one channel were set to 20 to compensate for extreme quotients. Loess normalization was used///platform_id: GPL5886///contact_name: Karolina,,Partheen///contact_email: karolina.partheen@gu.se///contact_phone: +46+31 342 78 55///contact_fax: +46 +31 41 72 05///contact_department: department of Oncology///contact_institute: University of Gothenburg///contact_address: Bl Strket 2///contact_city: Gothenburg///contact_zip.postal_code: 413 45///contact_country: Sweden///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM311nnn/GSM311958/GSM311958.gpr.gz///data_row_count: 30000"
"GSM311959"	"489DC"	NA	"tumor"	"ser"	"ov"	NA	NA	"late"	3	"c"	NA	64	"y"	NA	NA	NA	NA	NA	NA	"short"	NA	NA	NA	"suboptimal"	NA	NA	NA	NA	"title: 489DC///geo_accession: GSM311959///status: Public on Aug 12 2008///submission_date: Aug 12 2008///last_update_date: Aug 13 2008///type: RNA///channel_count: 2///source_name_ch1: serous ovarian adenocarcinoma///organism_ch1: Homo sapiens///characteristics_ch1: fresh frozen tumour///characteristics_ch1.1: deceased///characteristics_ch1.2: stage IIIc///characteristics_ch1.3: macroscopic residual tumor///characteristics_ch1.4: age at diagnosis 64///characteristics_ch1.5: post surgical chemo therapy farmorubicine, carboplatin and cyclophosphamide///molecule_ch1: total RNA///extract_protocol_ch1: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch1: Cy3///label_protocol_ch1: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch1: 9606///source_name_ch2: Universal Human Reference RNA purchased from Stratagene///organism_ch2: Homo sapiens///characteristics_ch2: Reference///molecule_ch2: total RNA///extract_protocol_ch2: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch2: Cy5///label_protocol_ch2: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch2: 9606///hyb_protocol: The probes were purified using ChipShot labelling cleanup system (Promega). The hybridizations were carried out using Pronto! Micro Array reagent systems (Corning Inc.). For each sample, labelled tumour cDNA and reference cDNA were co-precipitated and hybridised to the oligoarray slide.  After hybridization, slides were washed sequential.///scan_protocol: Scanned on an Agilent G2565AA scanner.///scan_protocol.1: Images were quantified using Genepix 6.0.0.74 (Axon Instruments).///description: Comparison of ovarian tumors of 5 year survivors to deceased patients///data_processing: Intensities were calculated by mean spot - median background. Flagged spots were removed as well as spots with intensities below 20 in both channels. Intensities below 20 in one channel were set to 20 to compensate for extreme quotients. Loess normalization was used///platform_id: GPL5886///contact_name: Karolina,,Partheen///contact_email: karolina.partheen@gu.se///contact_phone: +46+31 342 78 55///contact_fax: +46 +31 41 72 05///contact_department: department of Oncology///contact_institute: University of Gothenburg///contact_address: Bl Strket 2///contact_city: Gothenburg///contact_zip.postal_code: 413 45///contact_country: Sweden///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM311nnn/GSM311959/GSM311959.gpr.gz///data_row_count: 30000"
"GSM311960"	"505DB"	NA	"tumor"	"ser"	"ov"	NA	NA	"late"	3	"b"	NA	74	"y"	NA	NA	NA	NA	NA	NA	"short"	NA	NA	NA	"suboptimal"	NA	NA	NA	NA	"title: 505DB///geo_accession: GSM311960///status: Public on Aug 12 2008///submission_date: Aug 12 2008///last_update_date: Aug 13 2008///type: RNA///channel_count: 2///source_name_ch1: serous ovarian adenocarcinoma///organism_ch1: Homo sapiens///characteristics_ch1: fresh frozen tumour///characteristics_ch1.1: deceased///characteristics_ch1.2: stage IIIab///characteristics_ch1.3: macroscopic residual tumor///characteristics_ch1.4: age at diagnosis 74///characteristics_ch1.5: post surgical chemo therapy farmorubicine, carboplatin and cyclophosphamide///molecule_ch1: total RNA///extract_protocol_ch1: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch1: Cy3///label_protocol_ch1: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch1: 9606///source_name_ch2: Universal Human Reference RNA purchased from Stratagene///organism_ch2: Homo sapiens///characteristics_ch2: Reference///molecule_ch2: total RNA///extract_protocol_ch2: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch2: Cy5///label_protocol_ch2: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch2: 9606///hyb_protocol: The probes were purified using ChipShot labelling cleanup system (Promega). The hybridizations were carried out using Pronto! Micro Array reagent systems (Corning Inc.). For each sample, labelled tumour cDNA and reference cDNA were co-precipitated and hybridised to the oligoarray slide.  After hybridization, slides were washed sequential.///scan_protocol: Scanned on an Agilent G2565AA scanner.///scan_protocol.1: Images were quantified using Genepix 6.0.0.74 (Axon Instruments).///description: Comparison of ovarian tumors of 5 year survivors to deceased patients///data_processing: Intensities were calculated by mean spot - median background. Flagged spots were removed as well as spots with intensities below 20 in both channels. Intensities below 20 in one channel were set to 20 to compensate for extreme quotients. Loess normalization was used///platform_id: GPL5886///contact_name: Karolina,,Partheen///contact_email: karolina.partheen@gu.se///contact_phone: +46+31 342 78 55///contact_fax: +46 +31 41 72 05///contact_department: department of Oncology///contact_institute: University of Gothenburg///contact_address: Bl Strket 2///contact_city: Gothenburg///contact_zip.postal_code: 413 45///contact_country: Sweden///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM311nnn/GSM311960/GSM311960.gpr.gz///data_row_count: 30000"
"GSM311961"	"541DC"	NA	"tumor"	"ser"	"ov"	NA	NA	"late"	3	"c"	NA	64	"y"	NA	NA	NA	NA	NA	NA	"short"	NA	NA	NA	"suboptimal"	NA	NA	NA	NA	"title: 541DC///geo_accession: GSM311961///status: Public on Aug 12 2008///submission_date: Aug 12 2008///last_update_date: Aug 13 2008///type: RNA///channel_count: 2///source_name_ch1: serous ovarian adenocarcinoma///organism_ch1: Homo sapiens///characteristics_ch1: fresh frozen tumour///characteristics_ch1.1: deceased///characteristics_ch1.2: stage IIIc///characteristics_ch1.3: macroscopic residual tumor///characteristics_ch1.4: age at diagnosis 64///characteristics_ch1.5: post surgical chemo therapy farmorubicine, carboplatin and cyclophosphamide///molecule_ch1: total RNA///extract_protocol_ch1: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch1: Cy3///label_protocol_ch1: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch1: 9606///source_name_ch2: Universal Human Reference RNA purchased from Stratagene///organism_ch2: Homo sapiens///characteristics_ch2: Reference///molecule_ch2: total RNA///extract_protocol_ch2: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch2: Cy5///label_protocol_ch2: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch2: 9606///hyb_protocol: The probes were purified using ChipShot labelling cleanup system (Promega). The hybridizations were carried out using Pronto! Micro Array reagent systems (Corning Inc.). For each sample, labelled tumour cDNA and reference cDNA were co-precipitated and hybridised to the oligoarray slide.  After hybridization, slides were washed sequential.///scan_protocol: Scanned on an Agilent G2565AA scanner.///scan_protocol.1: Images were quantified using Genepix 6.0.0.74 (Axon Instruments).///description: Comparison of ovarian tumors of 5 year survivors to deceased patients///data_processing: Intensities were calculated by mean spot - median background. Flagged spots were removed as well as spots with intensities below 20 in both channels. Intensities below 20 in one channel were set to 20 to compensate for extreme quotients. Loess normalization was used///platform_id: GPL5886///contact_name: Karolina,,Partheen///contact_email: karolina.partheen@gu.se///contact_phone: +46+31 342 78 55///contact_fax: +46 +31 41 72 05///contact_department: department of Oncology///contact_institute: University of Gothenburg///contact_address: Bl Strket 2///contact_city: Gothenburg///contact_zip.postal_code: 413 45///contact_country: Sweden///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM311nnn/GSM311961/GSM311961.gpr.gz///data_row_count: 30000"
"GSM311962"	"559DC"	NA	"tumor"	"ser"	"ov"	NA	NA	"late"	3	"c"	NA	75	"y"	NA	NA	NA	NA	NA	NA	"short"	NA	NA	NA	"suboptimal"	NA	NA	NA	NA	"title: 559DC///geo_accession: GSM311962///status: Public on Aug 12 2008///submission_date: Aug 12 2008///last_update_date: Aug 13 2008///type: RNA///channel_count: 2///source_name_ch1: serous ovarian adenocarcinoma///organism_ch1: Homo sapiens///characteristics_ch1: fresh frozen tumour///characteristics_ch1.1: deceased///characteristics_ch1.2: stage IIIc///characteristics_ch1.3: macroscopic residual tumor///characteristics_ch1.4: age at diagnosis 75///characteristics_ch1.5: post surgical chemo therapy farmorubicine, carboplatin and cyclophosphamide///molecule_ch1: total RNA///extract_protocol_ch1: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch1: Cy3///label_protocol_ch1: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch1: 9606///source_name_ch2: Universal Human Reference RNA purchased from Stratagene///organism_ch2: Homo sapiens///characteristics_ch2: Reference///molecule_ch2: total RNA///extract_protocol_ch2: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch2: Cy5///label_protocol_ch2: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch2: 9606///hyb_protocol: The probes were purified using ChipShot labelling cleanup system (Promega). The hybridizations were carried out using Pronto! Micro Array reagent systems (Corning Inc.). For each sample, labelled tumour cDNA and reference cDNA were co-precipitated and hybridised to the oligoarray slide.  After hybridization, slides were washed sequential.///scan_protocol: Scanned on an Agilent G2565AA scanner.///scan_protocol.1: Images were quantified using Genepix 6.0.0.74 (Axon Instruments).///description: Comparison of ovarian tumors of 5 year survivors to deceased patients///data_processing: Intensities were calculated by mean spot - median background. Flagged spots were removed as well as spots with intensities below 20 in both channels. Intensities below 20 in one channel were set to 20 to compensate for extreme quotients. Loess normalization was used///platform_id: GPL5886///contact_name: Karolina,,Partheen///contact_email: karolina.partheen@gu.se///contact_phone: +46+31 342 78 55///contact_fax: +46 +31 41 72 05///contact_department: department of Oncology///contact_institute: University of Gothenburg///contact_address: Bl Strket 2///contact_city: Gothenburg///contact_zip.postal_code: 413 45///contact_country: Sweden///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM311nnn/GSM311962/GSM311962.gpr.gz///data_row_count: 30000"
"GSM311963"	"563LA"	NA	"tumor"	"ser"	"ov"	NA	NA	"late"	3	"b"	NA	62	"y"	NA	NA	NA	NA	NA	NA	"long"	NA	NA	NA	"suboptimal"	NA	NA	NA	NA	"title: 563LA///geo_accession: GSM311963///status: Public on Aug 12 2008///submission_date: Aug 12 2008///last_update_date: Aug 13 2008///type: RNA///channel_count: 2///source_name_ch1: serous ovarian adenocarcinoma///organism_ch1: Homo sapiens///characteristics_ch1: fresh frozen tumour///characteristics_ch1.1: 5 year survivor///characteristics_ch1.2: stage IIIab///characteristics_ch1.3: macroscopic residual tumor///characteristics_ch1.4: age at diagnosis 62///characteristics_ch1.5: post surgical chemo therapy farmorubicine, carboplatin and cyclophosphamide///molecule_ch1: total RNA///extract_protocol_ch1: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch1: Cy3///label_protocol_ch1: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch1: 9606///source_name_ch2: Universal Human Reference RNA purchased from Stratagene///organism_ch2: Homo sapiens///characteristics_ch2: Reference///molecule_ch2: total RNA///extract_protocol_ch2: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch2: Cy5///label_protocol_ch2: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch2: 9606///hyb_protocol: The probes were purified using ChipShot labelling cleanup system (Promega). The hybridizations were carried out using Pronto! Micro Array reagent systems (Corning Inc.). For each sample, labelled tumour cDNA and reference cDNA were co-precipitated and hybridised to the oligoarray slide.  After hybridization, slides were washed sequential.///scan_protocol: Scanned on an Agilent G2565AA scanner.///scan_protocol.1: Images were quantified using Genepix 6.0.0.74 (Axon Instruments).///description: Comparison of ovarian tumors of 5 year survivors to deceased patients///data_processing: Intensities were calculated by mean spot - median background. Flagged spots were removed as well as spots with intensities below 20 in both channels. Intensities below 20 in one channel were set to 20 to compensate for extreme quotients. Loess normalization was used///platform_id: GPL5886///contact_name: Karolina,,Partheen///contact_email: karolina.partheen@gu.se///contact_phone: +46+31 342 78 55///contact_fax: +46 +31 41 72 05///contact_department: department of Oncology///contact_institute: University of Gothenburg///contact_address: Bl Strket 2///contact_city: Gothenburg///contact_zip.postal_code: 413 45///contact_country: Sweden///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM311nnn/GSM311963/GSM311963.gpr.gz///data_row_count: 30000"
"GSM311964"	"626DC"	NA	"tumor"	"ser"	"ov"	NA	NA	"late"	3	"c"	NA	54	"y"	NA	NA	NA	NA	NA	NA	"short"	NA	NA	NA	"suboptimal"	NA	NA	NA	NA	"title: 626DC///geo_accession: GSM311964///status: Public on Aug 12 2008///submission_date: Aug 12 2008///last_update_date: Aug 13 2008///type: RNA///channel_count: 2///source_name_ch1: serous ovarian adenocarcinoma///organism_ch1: Homo sapiens///characteristics_ch1: fresh frozen tumour///characteristics_ch1.1: deceased///characteristics_ch1.2: stage IIIc///characteristics_ch1.3: macroscopic residual tumor///characteristics_ch1.4: age at diagnosis 54///characteristics_ch1.5: post surgical chemo therapy farmorubicine, carboplatin and cyclophosphamide///molecule_ch1: total RNA///extract_protocol_ch1: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch1: Cy3///label_protocol_ch1: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch1: 9606///source_name_ch2: Universal Human Reference RNA purchased from Stratagene///organism_ch2: Homo sapiens///characteristics_ch2: Reference///molecule_ch2: total RNA///extract_protocol_ch2: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch2: Cy5///label_protocol_ch2: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch2: 9606///hyb_protocol: The probes were purified using ChipShot labelling cleanup system (Promega). The hybridizations were carried out using Pronto! Micro Array reagent systems (Corning Inc.). For each sample, labelled tumour cDNA and reference cDNA were co-precipitated and hybridised to the oligoarray slide.  After hybridization, slides were washed sequential.///scan_protocol: Scanned on an Agilent G2565AA scanner.///scan_protocol.1: Images were quantified using Genepix 6.0.0.74 (Axon Instruments).///description: Comparison of ovarian tumors of 5 year survivors to deceased patients///data_processing: Intensities were calculated by mean spot - median background. Flagged spots were removed as well as spots with intensities below 20 in both channels. Intensities below 20 in one channel were set to 20 to compensate for extreme quotients. Loess normalization was used///platform_id: GPL5886///contact_name: Karolina,,Partheen///contact_email: karolina.partheen@gu.se///contact_phone: +46+31 342 78 55///contact_fax: +46 +31 41 72 05///contact_department: department of Oncology///contact_institute: University of Gothenburg///contact_address: Bl Strket 2///contact_city: Gothenburg///contact_zip.postal_code: 413 45///contact_country: Sweden///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM311nnn/GSM311964/GSM311964.gpr.gz///data_row_count: 30000"
"GSM311965"	"662DC"	NA	"tumor"	"ser"	"ov"	NA	NA	"late"	3	"c"	NA	65	"y"	NA	NA	NA	NA	NA	NA	"short"	NA	NA	NA	"suboptimal"	NA	NA	NA	NA	"title: 662DC///geo_accession: GSM311965///status: Public on Aug 12 2008///submission_date: Aug 12 2008///last_update_date: Aug 13 2008///type: RNA///channel_count: 2///source_name_ch1: serous ovarian adenocarcinoma///organism_ch1: Homo sapiens///characteristics_ch1: fresh frozen tumour///characteristics_ch1.1: deceased///characteristics_ch1.2: stage IIIc///characteristics_ch1.3: macroscopic residual tumor///characteristics_ch1.4: age at diagnosis 65///characteristics_ch1.5: post surgical chemo therapy farmorubicine, carboplatin and cyclophosphamide///molecule_ch1: total RNA///extract_protocol_ch1: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch1: Cy3///label_protocol_ch1: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch1: 9606///source_name_ch2: Universal Human Reference RNA purchased from Stratagene///organism_ch2: Homo sapiens///characteristics_ch2: Reference///molecule_ch2: total RNA///extract_protocol_ch2: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch2: Cy5///label_protocol_ch2: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch2: 9606///hyb_protocol: The probes were purified using ChipShot labelling cleanup system (Promega). The hybridizations were carried out using Pronto! Micro Array reagent systems (Corning Inc.). For each sample, labelled tumour cDNA and reference cDNA were co-precipitated and hybridised to the oligoarray slide.  After hybridization, slides were washed sequential.///scan_protocol: Scanned on an Agilent G2565AA scanner.///scan_protocol.1: Images were quantified using Genepix 6.0.0.74 (Axon Instruments).///description: Comparison of ovarian tumors of 5 year survivors to deceased patients///data_processing: Intensities were calculated by mean spot - median background. Flagged spots were removed as well as spots with intensities below 20 in both channels. Intensities below 20 in one channel were set to 20 to compensate for extreme quotients. Loess normalization was used///platform_id: GPL5886///contact_name: Karolina,,Partheen///contact_email: karolina.partheen@gu.se///contact_phone: +46+31 342 78 55///contact_fax: +46 +31 41 72 05///contact_department: department of Oncology///contact_institute: University of Gothenburg///contact_address: Bl Strket 2///contact_city: Gothenburg///contact_zip.postal_code: 413 45///contact_country: Sweden///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM311nnn/GSM311965/GSM311965.gpr.gz///data_row_count: 30000"
"GSM311966"	"719DC"	NA	"tumor"	"ser"	"ov"	NA	NA	"late"	3	"c"	NA	77	"y"	NA	NA	NA	NA	NA	NA	"short"	NA	NA	NA	"suboptimal"	NA	NA	NA	NA	"title: 719DC///geo_accession: GSM311966///status: Public on Aug 12 2008///submission_date: Aug 12 2008///last_update_date: Aug 13 2008///type: RNA///channel_count: 2///source_name_ch1: serous ovarian adenocarcinoma///organism_ch1: Homo sapiens///characteristics_ch1: fresh frozen tumour///characteristics_ch1.1: deceased///characteristics_ch1.2: stage IIIc///characteristics_ch1.3: macroscopic residual tumor///characteristics_ch1.4: age at diagnosis 77///characteristics_ch1.5: post surgical chemo therapy farmorubicine, carboplatin and cyclophosphamide///molecule_ch1: total RNA///extract_protocol_ch1: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch1: Cy3///label_protocol_ch1: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch1: 9606///source_name_ch2: Universal Human Reference RNA purchased from Stratagene///organism_ch2: Homo sapiens///characteristics_ch2: Reference///molecule_ch2: total RNA///extract_protocol_ch2: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch2: Cy5///label_protocol_ch2: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch2: 9606///hyb_protocol: The probes were purified using ChipShot labelling cleanup system (Promega). The hybridizations were carried out using Pronto! Micro Array reagent systems (Corning Inc.). For each sample, labelled tumour cDNA and reference cDNA were co-precipitated and hybridised to the oligoarray slide.  After hybridization, slides were washed sequential.///scan_protocol: Scanned on an Agilent G2565AA scanner.///scan_protocol.1: Images were quantified using Genepix 6.0.0.74 (Axon Instruments).///description: Comparison of ovarian tumors of 5 year survivors to deceased patients///data_processing: Intensities were calculated by mean spot - median background. Flagged spots were removed as well as spots with intensities below 20 in both channels. Intensities below 20 in one channel were set to 20 to compensate for extreme quotients. Loess normalization was used///platform_id: GPL5886///contact_name: Karolina,,Partheen///contact_email: karolina.partheen@gu.se///contact_phone: +46+31 342 78 55///contact_fax: +46 +31 41 72 05///contact_department: department of Oncology///contact_institute: University of Gothenburg///contact_address: Bl Strket 2///contact_city: Gothenburg///contact_zip.postal_code: 413 45///contact_country: Sweden///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM311nnn/GSM311966/GSM311966.gpr.gz///data_row_count: 30000"
"GSM311967"	"742LC0"	NA	"tumor"	"ser"	"ov"	NA	NA	"late"	3	"c"	NA	49	"y"	NA	NA	NA	NA	NA	NA	"long"	NA	NA	NA	"optimal"	NA	NA	NA	NA	"title: 742LC0///geo_accession: GSM311967///status: Public on Aug 12 2008///submission_date: Aug 12 2008///last_update_date: Aug 13 2008///type: RNA///channel_count: 2///source_name_ch1: serous ovarian adenocarcinoma///organism_ch1: Homo sapiens///characteristics_ch1: fresh frozen tumour///characteristics_ch1.1: 5 year survivor///characteristics_ch1.2: stage IIIc///characteristics_ch1.3: no macroscopic residual tumor///characteristics_ch1.4: age at diagnosis 49///characteristics_ch1.5: post surgical chemo therapy farmorubicine, carboplatin and cyclophosphamide///molecule_ch1: total RNA///extract_protocol_ch1: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch1: Cy3///label_protocol_ch1: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch1: 9606///source_name_ch2: Universal Human Reference RNA purchased from Stratagene///organism_ch2: Homo sapiens///characteristics_ch2: Reference///molecule_ch2: total RNA///extract_protocol_ch2: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch2: Cy5///label_protocol_ch2: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch2: 9606///hyb_protocol: The probes were purified using ChipShot labelling cleanup system (Promega). The hybridizations were carried out using Pronto! Micro Array reagent systems (Corning Inc.). For each sample, labelled tumour cDNA and reference cDNA were co-precipitated and hybridised to the oligoarray slide.  After hybridization, slides were washed sequential.///scan_protocol: Scanned on an Agilent G2565AA scanner.///scan_protocol.1: Images were quantified using Genepix 6.0.0.74 (Axon Instruments).///description: Comparison of ovarian tumors of 5 year survivors to deceased patients///data_processing: Intensities were calculated by mean spot - median background. Flagged spots were removed as well as spots with intensities below 20 in both channels. Intensities below 20 in one channel were set to 20 to compensate for extreme quotients. Loess normalization was used///platform_id: GPL5886///contact_name: Karolina,,Partheen///contact_email: karolina.partheen@gu.se///contact_phone: +46+31 342 78 55///contact_fax: +46 +31 41 72 05///contact_department: department of Oncology///contact_institute: University of Gothenburg///contact_address: Bl Strket 2///contact_city: Gothenburg///contact_zip.postal_code: 413 45///contact_country: Sweden///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM311nnn/GSM311967/GSM311967.gpr.gz///data_row_count: 30000"
"GSM311968"	"755LC"	NA	"tumor"	"ser"	"ov"	NA	NA	"late"	3	"c"	NA	77	"y"	NA	NA	NA	NA	NA	NA	"long"	NA	NA	NA	"suboptimal"	NA	NA	NA	NA	"title: 755LC///geo_accession: GSM311968///status: Public on Aug 12 2008///submission_date: Aug 12 2008///last_update_date: Aug 13 2008///type: RNA///channel_count: 2///source_name_ch1: serous ovarian adenocarcinoma///organism_ch1: Homo sapiens///characteristics_ch1: fresh frozen tumour///characteristics_ch1.1: 5 year survivor///characteristics_ch1.2: stage IIIc///characteristics_ch1.3: macroscopic residual tumor///characteristics_ch1.4: age at diagnosis 77///characteristics_ch1.5: post surgical chemo therapy farmorubicine, carboplatin and cyclophosphamide///molecule_ch1: total RNA///extract_protocol_ch1: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch1: Cy3///label_protocol_ch1: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch1: 9606///source_name_ch2: Universal Human Reference RNA purchased from Stratagene///organism_ch2: Homo sapiens///characteristics_ch2: Reference///molecule_ch2: total RNA///extract_protocol_ch2: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch2: Cy5///label_protocol_ch2: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch2: 9606///hyb_protocol: The probes were purified using ChipShot labelling cleanup system (Promega). The hybridizations were carried out using Pronto! Micro Array reagent systems (Corning Inc.). For each sample, labelled tumour cDNA and reference cDNA were co-precipitated and hybridised to the oligoarray slide.  After hybridization, slides were washed sequential.///scan_protocol: Scanned on an Agilent G2565AA scanner.///scan_protocol.1: Images were quantified using Genepix 6.0.0.74 (Axon Instruments).///description: Comparison of ovarian tumors of 5 year survivors to deceased patients///data_processing: Intensities were calculated by mean spot - median background. Flagged spots were removed as well as spots with intensities below 20 in both channels. Intensities below 20 in one channel were set to 20 to compensate for extreme quotients. Loess normalization was used///platform_id: GPL5886///contact_name: Karolina,,Partheen///contact_email: karolina.partheen@gu.se///contact_phone: +46+31 342 78 55///contact_fax: +46 +31 41 72 05///contact_department: department of Oncology///contact_institute: University of Gothenburg///contact_address: Bl Strket 2///contact_city: Gothenburg///contact_zip.postal_code: 413 45///contact_country: Sweden///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM311nnn/GSM311968/GSM311968.gpr.gz///data_row_count: 30000"
"GSM311969"	"759DC"	NA	"tumor"	"ser"	"ov"	NA	NA	"late"	3	"c"	NA	52	"y"	NA	NA	NA	NA	NA	NA	"short"	NA	NA	NA	"suboptimal"	NA	NA	NA	NA	"title: 759DC///geo_accession: GSM311969///status: Public on Aug 12 2008///submission_date: Aug 12 2008///last_update_date: Aug 13 2008///type: RNA///channel_count: 2///source_name_ch1: serous ovarian adenocarcinoma///organism_ch1: Homo sapiens///characteristics_ch1: fresh frozen tumour///characteristics_ch1.1: deceased///characteristics_ch1.2: stage IIIc///characteristics_ch1.3: macroscopic residual tumor///characteristics_ch1.4: age at diagnosis 52///characteristics_ch1.5: post surgical chemo therapy farmorubicine, carboplatin and cyclophosphamide///molecule_ch1: total RNA///extract_protocol_ch1: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch1: Cy3///label_protocol_ch1: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch1: 9606///source_name_ch2: Universal Human Reference RNA purchased from Stratagene///organism_ch2: Homo sapiens///characteristics_ch2: Reference///molecule_ch2: total RNA///extract_protocol_ch2: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch2: Cy5///label_protocol_ch2: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch2: 9606///hyb_protocol: The probes were purified using ChipShot labelling cleanup system (Promega). The hybridizations were carried out using Pronto! Micro Array reagent systems (Corning Inc.). For each sample, labelled tumour cDNA and reference cDNA were co-precipitated and hybridised to the oligoarray slide.  After hybridization, slides were washed sequential.///scan_protocol: Scanned on an Agilent G2565AA scanner.///scan_protocol.1: Images were quantified using Genepix 6.0.0.74 (Axon Instruments).///description: Comparison of ovarian tumors of 5 year survivors to deceased patients///data_processing: Intensities were calculated by mean spot - median background. Flagged spots were removed as well as spots with intensities below 20 in both channels. Intensities below 20 in one channel were set to 20 to compensate for extreme quotients. Loess normalization was used///platform_id: GPL5886///contact_name: Karolina,,Partheen///contact_email: karolina.partheen@gu.se///contact_phone: +46+31 342 78 55///contact_fax: +46 +31 41 72 05///contact_department: department of Oncology///contact_institute: University of Gothenburg///contact_address: Bl Strket 2///contact_city: Gothenburg///contact_zip.postal_code: 413 45///contact_country: Sweden///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM311nnn/GSM311969/GSM311969.gpr.gz///data_row_count: 30000"
"GSM311970"	"789DC"	NA	"tumor"	"ser"	"ov"	NA	NA	"late"	3	"c"	NA	63	"y"	NA	NA	NA	NA	NA	NA	"short"	NA	NA	NA	"suboptimal"	NA	NA	NA	NA	"title: 789DC///geo_accession: GSM311970///status: Public on Aug 12 2008///submission_date: Aug 12 2008///last_update_date: Aug 13 2008///type: RNA///channel_count: 2///source_name_ch1: serous ovarian adenocarcinoma///organism_ch1: Homo sapiens///characteristics_ch1: fresh frozen tumour///characteristics_ch1.1: deceased///characteristics_ch1.2: stage IIIc///characteristics_ch1.3: macroscopic residual tumor///characteristics_ch1.4: age at diagnosis 63///characteristics_ch1.5: post surgical chemo therapy farmorubicine, carboplatin and cyclophosphamide///molecule_ch1: total RNA///extract_protocol_ch1: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch1: Cy3///label_protocol_ch1: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch1: 9606///source_name_ch2: Universal Human Reference RNA purchased from Stratagene///organism_ch2: Homo sapiens///characteristics_ch2: Reference///molecule_ch2: total RNA///extract_protocol_ch2: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch2: Cy5///label_protocol_ch2: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch2: 9606///hyb_protocol: The probes were purified using ChipShot labelling cleanup system (Promega). The hybridizations were carried out using Pronto! Micro Array reagent systems (Corning Inc.). For each sample, labelled tumour cDNA and reference cDNA were co-precipitated and hybridised to the oligoarray slide.  After hybridization, slides were washed sequential.///scan_protocol: Scanned on an Agilent G2565AA scanner.///scan_protocol.1: Images were quantified using Genepix 6.0.0.74 (Axon Instruments).///description: Comparison of ovarian tumors of 5 year survivors to deceased patients///data_processing: Intensities were calculated by mean spot - median background. Flagged spots were removed as well as spots with intensities below 20 in both channels. Intensities below 20 in one channel were set to 20 to compensate for extreme quotients. Loess normalization was used///platform_id: GPL5886///contact_name: Karolina,,Partheen///contact_email: karolina.partheen@gu.se///contact_phone: +46+31 342 78 55///contact_fax: +46 +31 41 72 05///contact_department: department of Oncology///contact_institute: University of Gothenburg///contact_address: Bl Strket 2///contact_city: Gothenburg///contact_zip.postal_code: 413 45///contact_country: Sweden///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM311nnn/GSM311970/GSM311970.gpr.gz///data_row_count: 30000"
"GSM311971"	"918DB0"	NA	"tumor"	"ser"	"ov"	NA	NA	"late"	3	"b"	NA	70	"y"	NA	NA	NA	NA	NA	NA	"short"	NA	NA	NA	"optimal"	NA	NA	NA	NA	"title: 918DB0///geo_accession: GSM311971///status: Public on Aug 12 2008///submission_date: Aug 12 2008///last_update_date: Aug 13 2008///type: RNA///channel_count: 2///source_name_ch1: serous ovarian adenocarcinoma///organism_ch1: Homo sapiens///characteristics_ch1: fresh frozen tumour///characteristics_ch1.1: deceased///characteristics_ch1.2: stage IIIab///characteristics_ch1.3: no macroscopic residual tumor///characteristics_ch1.4: age at diagnosis 70///characteristics_ch1.5: post surgical chemo therapy farmorubicine, carboplatin and cyclophosphamide///molecule_ch1: total RNA///extract_protocol_ch1: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch1: Cy3///label_protocol_ch1: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch1: 9606///source_name_ch2: Universal Human Reference RNA purchased from Stratagene///organism_ch2: Homo sapiens///characteristics_ch2: Reference///molecule_ch2: total RNA///extract_protocol_ch2: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch2: Cy5///label_protocol_ch2: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch2: 9606///hyb_protocol: The probes were purified using ChipShot labelling cleanup system (Promega). The hybridizations were carried out using Pronto! Micro Array reagent systems (Corning Inc.). For each sample, labelled tumour cDNA and reference cDNA were co-precipitated and hybridised to the oligoarray slide.  After hybridization, slides were washed sequential.///scan_protocol: Scanned on an Agilent G2565AA scanner.///scan_protocol.1: Images were quantified using Genepix 6.0.0.74 (Axon Instruments).///description: Comparison of ovarian tumors of 5 year survivors to deceased patients///data_processing: Intensities were calculated by mean spot - median background. Flagged spots were removed as well as spots with intensities below 20 in both channels. Intensities below 20 in one channel were set to 20 to compensate for extreme quotients. Loess normalization was used///platform_id: GPL5886///contact_name: Karolina,,Partheen///contact_email: karolina.partheen@gu.se///contact_phone: +46+31 342 78 55///contact_fax: +46 +31 41 72 05///contact_department: department of Oncology///contact_institute: University of Gothenburg///contact_address: Bl Strket 2///contact_city: Gothenburg///contact_zip.postal_code: 413 45///contact_country: Sweden///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM311nnn/GSM311971/GSM311971.gpr.gz///data_row_count: 30000"
"GSM311972"	"988LC0"	NA	"tumor"	"ser"	"ov"	NA	NA	"late"	3	"c"	NA	52	"y"	NA	NA	NA	NA	NA	NA	"long"	NA	NA	NA	"optimal"	NA	NA	NA	NA	"title: 988LC0///geo_accession: GSM311972///status: Public on Aug 12 2008///submission_date: Aug 12 2008///last_update_date: Aug 13 2008///type: RNA///channel_count: 2///source_name_ch1: serous ovarian adenocarcinoma///organism_ch1: Homo sapiens///characteristics_ch1: fresh frozen tumour///characteristics_ch1.1: 5 year survivor///characteristics_ch1.2: stage IIIc///characteristics_ch1.3: no macroscopic residual tumor///characteristics_ch1.4: age at diagnosis 52///characteristics_ch1.5: post surgical chemo therapy farmorubicine, carboplatin and cyclophosphamide///molecule_ch1: total RNA///extract_protocol_ch1: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch1: Cy3///label_protocol_ch1: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch1: 9606///source_name_ch2: Universal Human Reference RNA purchased from Stratagene///organism_ch2: Homo sapiens///characteristics_ch2: Reference///molecule_ch2: total RNA///extract_protocol_ch2: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch2: Cy5///label_protocol_ch2: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch2: 9606///hyb_protocol: The probes were purified using ChipShot labelling cleanup system (Promega). The hybridizations were carried out using Pronto! Micro Array reagent systems (Corning Inc.). For each sample, labelled tumour cDNA and reference cDNA were co-precipitated and hybridised to the oligoarray slide.  After hybridization, slides were washed sequential.///scan_protocol: Scanned on an Agilent G2565AA scanner.///scan_protocol.1: Images were quantified using Genepix 6.0.0.74 (Axon Instruments).///description: Comparison of ovarian tumors of 5 year survivors to deceased patients///data_processing: Intensities were calculated by mean spot - median background. Flagged spots were removed as well as spots with intensities below 20 in both channels. Intensities below 20 in one channel were set to 20 to compensate for extreme quotients. Loess normalization was used///platform_id: GPL5886///contact_name: Karolina,,Partheen///contact_email: karolina.partheen@gu.se///contact_phone: +46+31 342 78 55///contact_fax: +46 +31 41 72 05///contact_department: department of Oncology///contact_institute: University of Gothenburg///contact_address: Bl Strket 2///contact_city: Gothenburg///contact_zip.postal_code: 413 45///contact_country: Sweden///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM311nnn/GSM311972/GSM311972.gpr.gz///data_row_count: 30000"
"GSM311973"	"1035LA0"	NA	"tumor"	"ser"	"ov"	NA	NA	"late"	3	"b"	NA	36	"y"	NA	NA	NA	NA	NA	NA	"long"	NA	NA	NA	"optimal"	NA	NA	NA	NA	"title: 1035LA0///geo_accession: GSM311973///status: Public on Aug 12 2008///submission_date: Aug 12 2008///last_update_date: Aug 13 2008///type: RNA///channel_count: 2///source_name_ch1: serous ovarian adenocarcinoma///organism_ch1: Homo sapiens///characteristics_ch1: fresh frozen tumour///characteristics_ch1.1: 5 year survivor///characteristics_ch1.2: stage IIIab///characteristics_ch1.3: no macroscopic residual tumor///characteristics_ch1.4: age at diagnosis 36///characteristics_ch1.5: post surgical chemo therapy farmorubicine, carboplatin and cyclophosphamide///molecule_ch1: total RNA///extract_protocol_ch1: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch1: Cy3///label_protocol_ch1: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch1: 9606///source_name_ch2: Universal Human Reference RNA purchased from Stratagene///organism_ch2: Homo sapiens///characteristics_ch2: Reference///molecule_ch2: total RNA///extract_protocol_ch2: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch2: Cy5///label_protocol_ch2: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch2: 9606///hyb_protocol: The probes were purified using ChipShot labelling cleanup system (Promega). The hybridizations were carried out using Pronto! Micro Array reagent systems (Corning Inc.). For each sample, labelled tumour cDNA and reference cDNA were co-precipitated and hybridised to the oligoarray slide.  After hybridization, slides were washed sequential.///scan_protocol: Scanned on an Agilent G2565AA scanner.///scan_protocol.1: Images were quantified using Genepix 6.0.0.74 (Axon Instruments).///description: Comparison of ovarian tumors of 5 year survivors to deceased patients///data_processing: Intensities were calculated by mean spot - median background. Flagged spots were removed as well as spots with intensities below 20 in both channels. Intensities below 20 in one channel were set to 20 to compensate for extreme quotients. Loess normalization was used///platform_id: GPL5886///contact_name: Karolina,,Partheen///contact_email: karolina.partheen@gu.se///contact_phone: +46+31 342 78 55///contact_fax: +46 +31 41 72 05///contact_department: department of Oncology///contact_institute: University of Gothenburg///contact_address: Bl Strket 2///contact_city: Gothenburg///contact_zip.postal_code: 413 45///contact_country: Sweden///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM311nnn/GSM311973/GSM311973.gpr.gz///data_row_count: 30000"
"GSM311974"	"1047LB"	NA	"tumor"	"ser"	"ov"	NA	NA	"late"	3	"b"	NA	44	"y"	NA	NA	NA	NA	NA	NA	"long"	NA	NA	NA	"suboptimal"	NA	NA	NA	NA	"title: 1047LB///geo_accession: GSM311974///status: Public on Aug 12 2008///submission_date: Aug 12 2008///last_update_date: Aug 13 2008///type: RNA///channel_count: 2///source_name_ch1: serous ovarian adenocarcinoma///organism_ch1: Homo sapiens///characteristics_ch1: fresh frozen tumour///characteristics_ch1.1: 5 year survivor///characteristics_ch1.2: stage IIIab///characteristics_ch1.3: macroscopic residual tumor///characteristics_ch1.4: age at diagnosis 44///characteristics_ch1.5: post surgical chemo therapy farmorubicine, carboplatin and cyclophosphamide///molecule_ch1: total RNA///extract_protocol_ch1: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch1: Cy3///label_protocol_ch1: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch1: 9606///source_name_ch2: Universal Human Reference RNA purchased from Stratagene///organism_ch2: Homo sapiens///characteristics_ch2: Reference///molecule_ch2: total RNA///extract_protocol_ch2: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch2: Cy5///label_protocol_ch2: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch2: 9606///hyb_protocol: The probes were purified using ChipShot labelling cleanup system (Promega). The hybridizations were carried out using Pronto! Micro Array reagent systems (Corning Inc.). For each sample, labelled tumour cDNA and reference cDNA were co-precipitated and hybridised to the oligoarray slide.  After hybridization, slides were washed sequential.///scan_protocol: Scanned on an Agilent G2565AA scanner.///scan_protocol.1: Images were quantified using Genepix 6.0.0.74 (Axon Instruments).///description: Comparison of ovarian tumors of 5 year survivors to deceased patients///data_processing: Intensities were calculated by mean spot - median background. Flagged spots were removed as well as spots with intensities below 20 in both channels. Intensities below 20 in one channel were set to 20 to compensate for extreme quotients. Loess normalization was used///platform_id: GPL5886///contact_name: Karolina,,Partheen///contact_email: karolina.partheen@gu.se///contact_phone: +46+31 342 78 55///contact_fax: +46 +31 41 72 05///contact_department: department of Oncology///contact_institute: University of Gothenburg///contact_address: Bl Strket 2///contact_city: Gothenburg///contact_zip.postal_code: 413 45///contact_country: Sweden///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM311nnn/GSM311974/GSM311974.gpr.gz///data_row_count: 30000"
"GSM311975"	"1059LB0"	NA	"tumor"	"ser"	"ov"	NA	NA	"late"	3	"b"	NA	84	"y"	NA	NA	NA	NA	NA	NA	"long"	NA	NA	NA	"optimal"	NA	NA	NA	NA	"title: 1059LB0///geo_accession: GSM311975///status: Public on Aug 12 2008///submission_date: Aug 12 2008///last_update_date: Aug 13 2008///type: RNA///channel_count: 2///source_name_ch1: serous ovarian adenocarcinoma///organism_ch1: Homo sapiens///characteristics_ch1: fresh frozen tumour///characteristics_ch1.1: 5 year survivor///characteristics_ch1.2: stage IIIab///characteristics_ch1.3: no macroscopic residual tumor///characteristics_ch1.4: age at diagnosis 84///characteristics_ch1.5: post surgical chemo therapy farmorubicine, carboplatin and cyclophosphamide///molecule_ch1: total RNA///extract_protocol_ch1: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch1: Cy3///label_protocol_ch1: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch1: 9606///source_name_ch2: Universal Human Reference RNA purchased from Stratagene///organism_ch2: Homo sapiens///characteristics_ch2: Reference///molecule_ch2: total RNA///extract_protocol_ch2: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch2: Cy5///label_protocol_ch2: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch2: 9606///hyb_protocol: The probes were purified using ChipShot labelling cleanup system (Promega). The hybridizations were carried out using Pronto! Micro Array reagent systems (Corning Inc.). For each sample, labelled tumour cDNA and reference cDNA were co-precipitated and hybridised to the oligoarray slide.  After hybridization, slides were washed sequential.///scan_protocol: Scanned on an Agilent G2565AA scanner.///scan_protocol.1: Images were quantified using Genepix 6.0.0.74 (Axon Instruments).///description: Comparison of ovarian tumors of 5 year survivors to deceased patients///data_processing: Intensities were calculated by mean spot - median background. Flagged spots were removed as well as spots with intensities below 20 in both channels. Intensities below 20 in one channel were set to 20 to compensate for extreme quotients. Loess normalization was used///platform_id: GPL5886///contact_name: Karolina,,Partheen///contact_email: karolina.partheen@gu.se///contact_phone: +46+31 342 78 55///contact_fax: +46 +31 41 72 05///contact_department: department of Oncology///contact_institute: University of Gothenburg///contact_address: Bl Strket 2///contact_city: Gothenburg///contact_zip.postal_code: 413 45///contact_country: Sweden///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM311nnn/GSM311975/GSM311975.gpr.gz///data_row_count: 30000"
"GSM311976"	"1177DB"	NA	"tumor"	"ser"	"ov"	NA	NA	"late"	3	"b"	NA	55	"y"	NA	NA	NA	NA	NA	NA	"short"	NA	NA	NA	"suboptimal"	NA	NA	NA	NA	"title: 1177DB///geo_accession: GSM311976///status: Public on Aug 12 2008///submission_date: Aug 12 2008///last_update_date: Aug 13 2008///type: RNA///channel_count: 2///source_name_ch1: serous ovarian adenocarcinoma///organism_ch1: Homo sapiens///characteristics_ch1: fresh frozen tumour///characteristics_ch1.1: deceased///characteristics_ch1.2: stage IIIab///characteristics_ch1.3: macroscopic residual tumor///characteristics_ch1.4: age at diagnosis 55///characteristics_ch1.5: post surgical chemo therapy farmorubicine, carboplatin and cyclophosphamide///molecule_ch1: total RNA///extract_protocol_ch1: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch1: Cy3///label_protocol_ch1: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch1: 9606///source_name_ch2: Universal Human Reference RNA purchased from Stratagene///organism_ch2: Homo sapiens///characteristics_ch2: Reference///molecule_ch2: total RNA///extract_protocol_ch2: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch2: Cy5///label_protocol_ch2: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch2: 9606///hyb_protocol: The probes were purified using ChipShot labelling cleanup system (Promega). The hybridizations were carried out using Pronto! Micro Array reagent systems (Corning Inc.). For each sample, labelled tumour cDNA and reference cDNA were co-precipitated and hybridised to the oligoarray slide.  After hybridization, slides were washed sequential.///scan_protocol: Scanned on an Agilent G2565AA scanner.///scan_protocol.1: Images were quantified using Genepix 6.0.0.74 (Axon Instruments).///description: Comparison of ovarian tumors of 5 year survivors to deceased patients///data_processing: Intensities were calculated by mean spot - median background. Flagged spots were removed as well as spots with intensities below 20 in both channels. Intensities below 20 in one channel were set to 20 to compensate for extreme quotients. Loess normalization was used///platform_id: GPL5886///contact_name: Karolina,,Partheen///contact_email: karolina.partheen@gu.se///contact_phone: +46+31 342 78 55///contact_fax: +46 +31 41 72 05///contact_department: department of Oncology///contact_institute: University of Gothenburg///contact_address: Bl Strket 2///contact_city: Gothenburg///contact_zip.postal_code: 413 45///contact_country: Sweden///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM311nnn/GSM311976/GSM311976.gpr.gz///data_row_count: 30000"
"GSM311977"	"1178LB0"	NA	"tumor"	"ser"	"ov"	NA	NA	"late"	3	"b"	NA	60	"y"	NA	NA	NA	NA	NA	NA	"long"	NA	NA	NA	"optimal"	NA	NA	NA	NA	"title: 1178LB0///geo_accession: GSM311977///status: Public on Aug 12 2008///submission_date: Aug 12 2008///last_update_date: Aug 13 2008///type: RNA///channel_count: 2///source_name_ch1: serous ovarian adenocarcinoma///organism_ch1: Homo sapiens///characteristics_ch1: fresh frozen tumour///characteristics_ch1.1: 5 year survivor///characteristics_ch1.2: stage IIIab///characteristics_ch1.3: no macroscopic residual tumor///characteristics_ch1.4: age at diagnosis 60///characteristics_ch1.5: post surgical chemo therapy farmorubicine, carboplatin and cyclophosphamide///molecule_ch1: total RNA///extract_protocol_ch1: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch1: Cy3///label_protocol_ch1: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch1: 9606///source_name_ch2: Universal Human Reference RNA purchased from Stratagene///organism_ch2: Homo sapiens///characteristics_ch2: Reference///molecule_ch2: total RNA///extract_protocol_ch2: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch2: Cy5///label_protocol_ch2: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch2: 9606///hyb_protocol: The probes were purified using ChipShot labelling cleanup system (Promega). The hybridizations were carried out using Pronto! Micro Array reagent systems (Corning Inc.). For each sample, labelled tumour cDNA and reference cDNA were co-precipitated and hybridised to the oligoarray slide.  After hybridization, slides were washed sequential.///scan_protocol: Scanned on an Agilent G2565AA scanner.///scan_protocol.1: Images were quantified using Genepix 6.0.0.74 (Axon Instruments).///description: Comparison of ovarian tumors of 5 year survivors to deceased patients///data_processing: Intensities were calculated by mean spot - median background. Flagged spots were removed as well as spots with intensities below 20 in both channels. Intensities below 20 in one channel were set to 20 to compensate for extreme quotients. Loess normalization was used///platform_id: GPL5886///contact_name: Karolina,,Partheen///contact_email: karolina.partheen@gu.se///contact_phone: +46+31 342 78 55///contact_fax: +46 +31 41 72 05///contact_department: department of Oncology///contact_institute: University of Gothenburg///contact_address: Bl Strket 2///contact_city: Gothenburg///contact_zip.postal_code: 413 45///contact_country: Sweden///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM311nnn/GSM311977/GSM311977.gpr.gz///data_row_count: 30000"
"GSM311978"	"1180DB"	NA	"tumor"	"ser"	"ov"	NA	NA	"late"	3	"b"	NA	43	"y"	NA	NA	NA	NA	NA	NA	"short"	NA	NA	NA	"suboptimal"	NA	NA	NA	NA	"title: 1180DB///geo_accession: GSM311978///status: Public on Aug 12 2008///submission_date: Aug 12 2008///last_update_date: Aug 13 2008///type: RNA///channel_count: 2///source_name_ch1: serous ovarian adenocarcinoma///organism_ch1: Homo sapiens///characteristics_ch1: fresh frozen tumour///characteristics_ch1.1: deceased///characteristics_ch1.2: stage IIIab///characteristics_ch1.3: macroscopic residual tumor///characteristics_ch1.4: age at diagnosis 43///characteristics_ch1.5: post surgical chemo therapy farmorubicine, carboplatin and cyclophosphamide///molecule_ch1: total RNA///extract_protocol_ch1: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch1: Cy3///label_protocol_ch1: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch1: 9606///source_name_ch2: Universal Human Reference RNA purchased from Stratagene///organism_ch2: Homo sapiens///characteristics_ch2: Reference///molecule_ch2: total RNA///extract_protocol_ch2: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch2: Cy5///label_protocol_ch2: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch2: 9606///hyb_protocol: The probes were purified using ChipShot labelling cleanup system (Promega). The hybridizations were carried out using Pronto! Micro Array reagent systems (Corning Inc.). For each sample, labelled tumour cDNA and reference cDNA were co-precipitated and hybridised to the oligoarray slide.  After hybridization, slides were washed sequential.///scan_protocol: Scanned on an Agilent G2565AA scanner.///scan_protocol.1: Images were quantified using Genepix 6.0.0.74 (Axon Instruments).///description: Comparison of ovarian tumors of 5 year survivors to deceased patients///data_processing: Intensities were calculated by mean spot - median background. Flagged spots were removed as well as spots with intensities below 20 in both channels. Intensities below 20 in one channel were set to 20 to compensate for extreme quotients. Loess normalization was used///platform_id: GPL5886///contact_name: Karolina,,Partheen///contact_email: karolina.partheen@gu.se///contact_phone: +46+31 342 78 55///contact_fax: +46 +31 41 72 05///contact_department: department of Oncology///contact_institute: University of Gothenburg///contact_address: Bl Strket 2///contact_city: Gothenburg///contact_zip.postal_code: 413 45///contact_country: Sweden///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM311nnn/GSM311978/GSM311978.gpr.gz///data_row_count: 30000"
"GSM311979"	"1186DB0"	NA	"tumor"	"ser"	"ov"	NA	NA	"late"	3	"b"	NA	65	"y"	NA	NA	NA	NA	NA	NA	"short"	NA	NA	NA	"optimal"	NA	NA	NA	NA	"title: 1186DB0///geo_accession: GSM311979///status: Public on Aug 12 2008///submission_date: Aug 12 2008///last_update_date: Aug 13 2008///type: RNA///channel_count: 2///source_name_ch1: serous ovarian adenocarcinoma///organism_ch1: Homo sapiens///characteristics_ch1: fresh frozen tumour///characteristics_ch1.1: deceased///characteristics_ch1.2: stage IIIab///characteristics_ch1.3: no macroscopic residual tumor///characteristics_ch1.4: age at diagnosis 65///characteristics_ch1.5: post surgical chemo therapy farmorubicine, carboplatin and cyclophosphamide///molecule_ch1: total RNA///extract_protocol_ch1: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch1: Cy3///label_protocol_ch1: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch1: 9606///source_name_ch2: Universal Human Reference RNA purchased from Stratagene///organism_ch2: Homo sapiens///characteristics_ch2: Reference///molecule_ch2: total RNA///extract_protocol_ch2: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch2: Cy5///label_protocol_ch2: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch2: 9606///hyb_protocol: The probes were purified using ChipShot labelling cleanup system (Promega). The hybridizations were carried out using Pronto! Micro Array reagent systems (Corning Inc.). For each sample, labelled tumour cDNA and reference cDNA were co-precipitated and hybridised to the oligoarray slide.  After hybridization, slides were washed sequential.///scan_protocol: Scanned on an Agilent G2565AA scanner.///scan_protocol.1: Images were quantified using Genepix 6.0.0.74 (Axon Instruments).///description: Comparison of ovarian tumors of 5 year survivors to deceased patients///data_processing: Intensities were calculated by mean spot - median background. Flagged spots were removed as well as spots with intensities below 20 in both channels. Intensities below 20 in one channel were set to 20 to compensate for extreme quotients. Loess normalization was used///platform_id: GPL5886///contact_name: Karolina,,Partheen///contact_email: karolina.partheen@gu.se///contact_phone: +46+31 342 78 55///contact_fax: +46 +31 41 72 05///contact_department: department of Oncology///contact_institute: University of Gothenburg///contact_address: Bl Strket 2///contact_city: Gothenburg///contact_zip.postal_code: 413 45///contact_country: Sweden///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM311nnn/GSM311979/GSM311979.gpr.gz///data_row_count: 30000"
"GSM311980"	"1242LC0"	NA	"tumor"	"ser"	"ov"	NA	NA	"late"	3	"c"	NA	70	"y"	NA	NA	NA	NA	NA	NA	"long"	NA	NA	NA	"optimal"	NA	NA	NA	NA	"title: 1242LC0///geo_accession: GSM311980///status: Public on Aug 12 2008///submission_date: Aug 12 2008///last_update_date: Aug 13 2008///type: RNA///channel_count: 2///source_name_ch1: serous ovarian adenocarcinoma///organism_ch1: Homo sapiens///characteristics_ch1: fresh frozen tumour///characteristics_ch1.1: 5 year survivor///characteristics_ch1.2: stage IIIc///characteristics_ch1.3: no macroscopic residual tumor///characteristics_ch1.4: age at diagnosis 70///characteristics_ch1.5: post surgical chemo therapy farmorubicine, carboplatin and cyclophosphamide///molecule_ch1: total RNA///extract_protocol_ch1: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch1: Cy3///label_protocol_ch1: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch1: 9606///source_name_ch2: Universal Human Reference RNA purchased from Stratagene///organism_ch2: Homo sapiens///characteristics_ch2: Reference///molecule_ch2: total RNA///extract_protocol_ch2: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch2: Cy5///label_protocol_ch2: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch2: 9606///hyb_protocol: The probes were purified using ChipShot labelling cleanup system (Promega). The hybridizations were carried out using Pronto! Micro Array reagent systems (Corning Inc.). For each sample, labelled tumour cDNA and reference cDNA were co-precipitated and hybridised to the oligoarray slide.  After hybridization, slides were washed sequential.///scan_protocol: Scanned on an Agilent G2565AA scanner.///scan_protocol.1: Images were quantified using Genepix 6.0.0.74 (Axon Instruments).///description: Comparison of ovarian tumors of 5 year survivors to deceased patients///data_processing: Intensities were calculated by mean spot - median background. Flagged spots were removed as well as spots with intensities below 20 in both channels. Intensities below 20 in one channel were set to 20 to compensate for extreme quotients. Loess normalization was used///platform_id: GPL5886///contact_name: Karolina,,Partheen///contact_email: karolina.partheen@gu.se///contact_phone: +46+31 342 78 55///contact_fax: +46 +31 41 72 05///contact_department: department of Oncology///contact_institute: University of Gothenburg///contact_address: Bl Strket 2///contact_city: Gothenburg///contact_zip.postal_code: 413 45///contact_country: Sweden///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM311nnn/GSM311980/GSM311980.gpr.gz///data_row_count: 30000"
"GSM311981"	"1274LC"	NA	"tumor"	"ser"	"ov"	NA	NA	"late"	3	"c"	NA	65	"y"	NA	NA	NA	NA	NA	NA	"long"	NA	NA	NA	"suboptimal"	NA	NA	NA	NA	"title: 1274LC///geo_accession: GSM311981///status: Public on Aug 12 2008///submission_date: Aug 12 2008///last_update_date: Aug 13 2008///type: RNA///channel_count: 2///source_name_ch1: serous ovarian adenocarcinoma///organism_ch1: Homo sapiens///characteristics_ch1: fresh frozen tumour///characteristics_ch1.1: 5 year survivor///characteristics_ch1.2: stage IIIc///characteristics_ch1.3: macroscopic residual tumor///characteristics_ch1.4: age at diagnosis 65///characteristics_ch1.5: post surgical chemo therapy farmorubicine, carboplatin and cyclophosphamide///molecule_ch1: total RNA///extract_protocol_ch1: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch1: Cy3///label_protocol_ch1: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch1: 9606///source_name_ch2: Universal Human Reference RNA purchased from Stratagene///organism_ch2: Homo sapiens///characteristics_ch2: Reference///molecule_ch2: total RNA///extract_protocol_ch2: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch2: Cy5///label_protocol_ch2: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch2: 9606///hyb_protocol: The probes were purified using ChipShot labelling cleanup system (Promega). The hybridizations were carried out using Pronto! Micro Array reagent systems (Corning Inc.). For each sample, labelled tumour cDNA and reference cDNA were co-precipitated and hybridised to the oligoarray slide.  After hybridization, slides were washed sequential.///scan_protocol: Scanned on an Agilent G2565AA scanner.///scan_protocol.1: Images were quantified using Genepix 6.0.0.74 (Axon Instruments).///description: Comparison of ovarian tumors of 5 year survivors to deceased patients///data_processing: Intensities were calculated by mean spot - median background. Flagged spots were removed as well as spots with intensities below 20 in both channels. Intensities below 20 in one channel were set to 20 to compensate for extreme quotients. Loess normalization was used///platform_id: GPL5886///contact_name: Karolina,,Partheen///contact_email: karolina.partheen@gu.se///contact_phone: +46+31 342 78 55///contact_fax: +46 +31 41 72 05///contact_department: department of Oncology///contact_institute: University of Gothenburg///contact_address: Bl Strket 2///contact_city: Gothenburg///contact_zip.postal_code: 413 45///contact_country: Sweden///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM311nnn/GSM311981/GSM311981.gpr.gz///data_row_count: 30000"
"GSM311982"	"1426LB"	NA	"tumor"	"ser"	"ov"	NA	NA	"late"	3	"b"	NA	54	"y"	NA	NA	NA	NA	NA	NA	"long"	NA	NA	NA	"suboptimal"	NA	NA	NA	NA	"title: 1426LB///geo_accession: GSM311982///status: Public on Aug 12 2008///submission_date: Aug 12 2008///last_update_date: Aug 13 2008///type: RNA///channel_count: 2///source_name_ch1: serous ovarian adenocarcinoma///organism_ch1: Homo sapiens///characteristics_ch1: fresh frozen tumour///characteristics_ch1.1: 5 year survivor///characteristics_ch1.2: stage IIIab///characteristics_ch1.3: macroscopic residual tumor///characteristics_ch1.4: age at diagnosis 54///characteristics_ch1.5: post surgical chemo therapy farmorubicine, carboplatin and cyclophosphamide///molecule_ch1: total RNA///extract_protocol_ch1: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch1: Cy3///label_protocol_ch1: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch1: 9606///source_name_ch2: Universal Human Reference RNA purchased from Stratagene///organism_ch2: Homo sapiens///characteristics_ch2: Reference///molecule_ch2: total RNA///extract_protocol_ch2: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch2: Cy5///label_protocol_ch2: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch2: 9606///hyb_protocol: The probes were purified using ChipShot labelling cleanup system (Promega). The hybridizations were carried out using Pronto! Micro Array reagent systems (Corning Inc.). For each sample, labelled tumour cDNA and reference cDNA were co-precipitated and hybridised to the oligoarray slide.  After hybridization, slides were washed sequential.///scan_protocol: Scanned on an Agilent G2565AA scanner.///scan_protocol.1: Images were quantified using Genepix 6.0.0.74 (Axon Instruments).///description: Comparison of ovarian tumors of 5 year survivors to deceased patients///data_processing: Intensities were calculated by mean spot - median background. Flagged spots were removed as well as spots with intensities below 20 in both channels. Intensities below 20 in one channel were set to 20 to compensate for extreme quotients. Loess normalization was used///platform_id: GPL5886///contact_name: Karolina,,Partheen///contact_email: karolina.partheen@gu.se///contact_phone: +46+31 342 78 55///contact_fax: +46 +31 41 72 05///contact_department: department of Oncology///contact_institute: University of Gothenburg///contact_address: Bl Strket 2///contact_city: Gothenburg///contact_zip.postal_code: 413 45///contact_country: Sweden///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM311nnn/GSM311982/GSM311982.gpr.gz///data_row_count: 30000"
"GSM311983"	"1487DB"	NA	"tumor"	"ser"	"ov"	NA	NA	"late"	3	"b"	NA	47	"y"	NA	NA	NA	NA	NA	NA	"short"	NA	NA	NA	"suboptimal"	NA	NA	NA	NA	"title: 1487DB///geo_accession: GSM311983///status: Public on Aug 12 2008///submission_date: Aug 12 2008///last_update_date: Aug 13 2008///type: RNA///channel_count: 2///source_name_ch1: serous ovarian adenocarcinoma///organism_ch1: Homo sapiens///characteristics_ch1: fresh frozen tumour///characteristics_ch1.1: deceased///characteristics_ch1.2: stage IIIab///characteristics_ch1.3: macroscopic residual tumor///characteristics_ch1.4: age at diagnosis 47///characteristics_ch1.5: post surgical chemo therapy farmorubicine, carboplatin and cyclophosphamide///molecule_ch1: total RNA///extract_protocol_ch1: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch1: Cy3///label_protocol_ch1: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch1: 9606///source_name_ch2: Universal Human Reference RNA purchased from Stratagene///organism_ch2: Homo sapiens///characteristics_ch2: Reference///molecule_ch2: total RNA///extract_protocol_ch2: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch2: Cy5///label_protocol_ch2: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch2: 9606///hyb_protocol: The probes were purified using ChipShot labelling cleanup system (Promega). The hybridizations were carried out using Pronto! Micro Array reagent systems (Corning Inc.). For each sample, labelled tumour cDNA and reference cDNA were co-precipitated and hybridised to the oligoarray slide.  After hybridization, slides were washed sequential.///scan_protocol: Scanned on an Agilent G2565AA scanner.///scan_protocol.1: Images were quantified using Genepix 6.0.0.74 (Axon Instruments).///description: Comparison of ovarian tumors of 5 year survivors to deceased patients///data_processing: Intensities were calculated by mean spot - median background. Flagged spots were removed as well as spots with intensities below 20 in both channels. Intensities below 20 in one channel were set to 20 to compensate for extreme quotients. Loess normalization was used///platform_id: GPL5886///contact_name: Karolina,,Partheen///contact_email: karolina.partheen@gu.se///contact_phone: +46+31 342 78 55///contact_fax: +46 +31 41 72 05///contact_department: department of Oncology///contact_institute: University of Gothenburg///contact_address: Bl Strket 2///contact_city: Gothenburg///contact_zip.postal_code: 413 45///contact_country: Sweden///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM311nnn/GSM311983/GSM311983.gpr.gz///data_row_count: 30000"
"GSM311984"	"1528DC"	NA	"tumor"	"ser"	"ov"	NA	NA	"late"	3	"c"	NA	50	"y"	NA	NA	NA	NA	NA	NA	"short"	NA	NA	NA	"suboptimal"	NA	NA	NA	NA	"title: 1528DC///geo_accession: GSM311984///status: Public on Aug 12 2008///submission_date: Aug 12 2008///last_update_date: Aug 13 2008///type: RNA///channel_count: 2///source_name_ch1: serous ovarian adenocarcinoma///organism_ch1: Homo sapiens///characteristics_ch1: fresh frozen tumour///characteristics_ch1.1: deceased///characteristics_ch1.2: stage IIIc///characteristics_ch1.3: macroscopic residual tumor///characteristics_ch1.4: age at diagnosis 50///characteristics_ch1.5: post surgical chemo therapy farmorubicine, carboplatin and cyclophosphamide///molecule_ch1: total RNA///extract_protocol_ch1: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch1: Cy3///label_protocol_ch1: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch1: 9606///source_name_ch2: Universal Human Reference RNA purchased from Stratagene///organism_ch2: Homo sapiens///characteristics_ch2: Reference///molecule_ch2: total RNA///extract_protocol_ch2: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch2: Cy5///label_protocol_ch2: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch2: 9606///hyb_protocol: The probes were purified using ChipShot labelling cleanup system (Promega). The hybridizations were carried out using Pronto! Micro Array reagent systems (Corning Inc.). For each sample, labelled tumour cDNA and reference cDNA were co-precipitated and hybridised to the oligoarray slide.  After hybridization, slides were washed sequential.///scan_protocol: Scanned on an Agilent G2565AA scanner.///scan_protocol.1: Images were quantified using Genepix 6.0.0.74 (Axon Instruments).///description: Comparison of ovarian tumors of 5 year survivors to deceased patients///data_processing: Intensities were calculated by mean spot - median background. Flagged spots were removed as well as spots with intensities below 20 in both channels. Intensities below 20 in one channel were set to 20 to compensate for extreme quotients. Loess normalization was used///platform_id: GPL5886///contact_name: Karolina,,Partheen///contact_email: karolina.partheen@gu.se///contact_phone: +46+31 342 78 55///contact_fax: +46 +31 41 72 05///contact_department: department of Oncology///contact_institute: University of Gothenburg///contact_address: Bl Strket 2///contact_city: Gothenburg///contact_zip.postal_code: 413 45///contact_country: Sweden///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM311nnn/GSM311984/GSM311984.gpr.gz///data_row_count: 30000"
"GSM311985"	"1538DC"	NA	"tumor"	"ser"	"ov"	NA	NA	"late"	3	"c"	NA	62	"y"	NA	NA	NA	NA	NA	NA	"short"	NA	NA	NA	"suboptimal"	NA	NA	NA	NA	"title: 1538DC///geo_accession: GSM311985///status: Public on Aug 12 2008///submission_date: Aug 12 2008///last_update_date: Aug 13 2008///type: RNA///channel_count: 2///source_name_ch1: serous ovarian adenocarcinoma///organism_ch1: Homo sapiens///characteristics_ch1: fresh frozen tumour///characteristics_ch1.1: deceased///characteristics_ch1.2: stage IIIc///characteristics_ch1.3: macroscopic residual tumor///characteristics_ch1.4: age at diagnosis 62///characteristics_ch1.5: post surgical chemo therapy farmorubicine, carboplatin and cyclophosphamide///molecule_ch1: total RNA///extract_protocol_ch1: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch1: Cy3///label_protocol_ch1: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch1: 9606///source_name_ch2: Universal Human Reference RNA purchased from Stratagene///organism_ch2: Homo sapiens///characteristics_ch2: Reference///molecule_ch2: total RNA///extract_protocol_ch2: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch2: Cy5///label_protocol_ch2: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch2: 9606///hyb_protocol: The probes were purified using ChipShot labelling cleanup system (Promega). The hybridizations were carried out using Pronto! Micro Array reagent systems (Corning Inc.). For each sample, labelled tumour cDNA and reference cDNA were co-precipitated and hybridised to the oligoarray slide.  After hybridization, slides were washed sequential.///scan_protocol: Scanned on an Agilent G2565AA scanner.///scan_protocol.1: Images were quantified using Genepix 6.0.0.74 (Axon Instruments).///description: Comparison of ovarian tumors of 5 year survivors to deceased patients///data_processing: Intensities were calculated by mean spot - median background. Flagged spots were removed as well as spots with intensities below 20 in both channels. Intensities below 20 in one channel were set to 20 to compensate for extreme quotients. Loess normalization was used///platform_id: GPL5886///contact_name: Karolina,,Partheen///contact_email: karolina.partheen@gu.se///contact_phone: +46+31 342 78 55///contact_fax: +46 +31 41 72 05///contact_department: department of Oncology///contact_institute: University of Gothenburg///contact_address: Bl Strket 2///contact_city: Gothenburg///contact_zip.postal_code: 413 45///contact_country: Sweden///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM311nnn/GSM311985/GSM311985.gpr.gz///data_row_count: 30000"
"GSM311986"	"1567DB"	NA	"tumor"	"ser"	"ov"	NA	NA	"late"	3	"b"	NA	68	"y"	NA	NA	NA	NA	NA	NA	"short"	NA	NA	NA	"suboptimal"	NA	NA	NA	NA	"title: 1567DB///geo_accession: GSM311986///status: Public on Aug 12 2008///submission_date: Aug 12 2008///last_update_date: Aug 13 2008///type: RNA///channel_count: 2///source_name_ch1: serous ovarian adenocarcinoma///organism_ch1: Homo sapiens///characteristics_ch1: fresh frozen tumour///characteristics_ch1.1: deceased///characteristics_ch1.2: stage IIIab///characteristics_ch1.3: macroscopic residual tumor///characteristics_ch1.4: age at diagnosis 68///characteristics_ch1.5: post surgical chemo therapy farmorubicine, carboplatin and cyclophosphamide///molecule_ch1: total RNA///extract_protocol_ch1: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch1: Cy3///label_protocol_ch1: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch1: 9606///source_name_ch2: Universal Human Reference RNA purchased from Stratagene///organism_ch2: Homo sapiens///characteristics_ch2: Reference///molecule_ch2: total RNA///extract_protocol_ch2: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch2: Cy5///label_protocol_ch2: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch2: 9606///hyb_protocol: The probes were purified using ChipShot labelling cleanup system (Promega). The hybridizations were carried out using Pronto! Micro Array reagent systems (Corning Inc.). For each sample, labelled tumour cDNA and reference cDNA were co-precipitated and hybridised to the oligoarray slide.  After hybridization, slides were washed sequential.///scan_protocol: Scanned on an Agilent G2565AA scanner.///scan_protocol.1: Images were quantified using Genepix 6.0.0.74 (Axon Instruments).///description: Comparison of ovarian tumors of 5 year survivors to deceased patients///data_processing: Intensities were calculated by mean spot - median background. Flagged spots were removed as well as spots with intensities below 20 in both channels. Intensities below 20 in one channel were set to 20 to compensate for extreme quotients. Loess normalization was used///platform_id: GPL5886///contact_name: Karolina,,Partheen///contact_email: karolina.partheen@gu.se///contact_phone: +46+31 342 78 55///contact_fax: +46 +31 41 72 05///contact_department: department of Oncology///contact_institute: University of Gothenburg///contact_address: Bl Strket 2///contact_city: Gothenburg///contact_zip.postal_code: 413 45///contact_country: Sweden///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM311nnn/GSM311986/GSM311986.gpr.gz///data_row_count: 30000"
"GSM311987"	"1568DC"	NA	"tumor"	"ser"	"ov"	NA	NA	"late"	3	"c"	NA	51	"y"	NA	NA	NA	NA	NA	NA	"short"	NA	NA	NA	"suboptimal"	NA	NA	NA	NA	"title: 1568DC///geo_accession: GSM311987///status: Public on Aug 12 2008///submission_date: Aug 12 2008///last_update_date: Aug 13 2008///type: RNA///channel_count: 2///source_name_ch1: serous ovarian adenocarcinoma///organism_ch1: Homo sapiens///characteristics_ch1: fresh frozen tumour///characteristics_ch1.1: deceased///characteristics_ch1.2: stage IIIc///characteristics_ch1.3: macroscopic residual tumor///characteristics_ch1.4: age at diagnosis 51///characteristics_ch1.5: post surgical chemo therapy farmorubicine, carboplatin and cyclophosphamide///molecule_ch1: total RNA///extract_protocol_ch1: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch1: Cy3///label_protocol_ch1: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch1: 9606///source_name_ch2: Universal Human Reference RNA purchased from Stratagene///organism_ch2: Homo sapiens///characteristics_ch2: Reference///molecule_ch2: total RNA///extract_protocol_ch2: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch2: Cy5///label_protocol_ch2: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch2: 9606///hyb_protocol: The probes were purified using ChipShot labelling cleanup system (Promega). The hybridizations were carried out using Pronto! Micro Array reagent systems (Corning Inc.). For each sample, labelled tumour cDNA and reference cDNA were co-precipitated and hybridised to the oligoarray slide.  After hybridization, slides were washed sequential.///scan_protocol: Scanned on an Agilent G2565AA scanner.///scan_protocol.1: Images were quantified using Genepix 6.0.0.74 (Axon Instruments).///description: Comparison of ovarian tumors of 5 year survivors to deceased patients///data_processing: Intensities were calculated by mean spot - median background. Flagged spots were removed as well as spots with intensities below 20 in both channels. Intensities below 20 in one channel were set to 20 to compensate for extreme quotients. Loess normalization was used///platform_id: GPL5886///contact_name: Karolina,,Partheen///contact_email: karolina.partheen@gu.se///contact_phone: +46+31 342 78 55///contact_fax: +46 +31 41 72 05///contact_department: department of Oncology///contact_institute: University of Gothenburg///contact_address: Bl Strket 2///contact_city: Gothenburg///contact_zip.postal_code: 413 45///contact_country: Sweden///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM311nnn/GSM311987/GSM311987.gpr.gz///data_row_count: 30000"
"GSM311988"	"1574LC0"	NA	"tumor"	"ser"	"ov"	NA	NA	"late"	3	"c"	NA	35	"y"	NA	NA	NA	NA	NA	NA	"long"	NA	NA	NA	"optimal"	NA	NA	NA	NA	"title: 1574LC0///geo_accession: GSM311988///status: Public on Aug 12 2008///submission_date: Aug 12 2008///last_update_date: Aug 13 2008///type: RNA///channel_count: 2///source_name_ch1: serous ovarian adenocarcinoma///organism_ch1: Homo sapiens///characteristics_ch1: fresh frozen tumour///characteristics_ch1.1: 5 year survivor///characteristics_ch1.2: stage IIIc///characteristics_ch1.3: no macroscopic residual tumor///characteristics_ch1.4: age at diagnosis 35///characteristics_ch1.5: post surgical chemo therapy farmorubicine, carboplatin and cyclophosphamide///molecule_ch1: total RNA///extract_protocol_ch1: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch1: Cy3///label_protocol_ch1: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch1: 9606///source_name_ch2: Universal Human Reference RNA purchased from Stratagene///organism_ch2: Homo sapiens///characteristics_ch2: Reference///molecule_ch2: total RNA///extract_protocol_ch2: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch2: Cy5///label_protocol_ch2: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch2: 9606///hyb_protocol: The probes were purified using ChipShot labelling cleanup system (Promega). The hybridizations were carried out using Pronto! Micro Array reagent systems (Corning Inc.). For each sample, labelled tumour cDNA and reference cDNA were co-precipitated and hybridised to the oligoarray slide.  After hybridization, slides were washed sequential.///scan_protocol: Scanned on an Agilent G2565AA scanner.///scan_protocol.1: Images were quantified using Genepix 6.0.0.74 (Axon Instruments).///description: Comparison of ovarian tumors of 5 year survivors to deceased patients///data_processing: Intensities were calculated by mean spot - median background. Flagged spots were removed as well as spots with intensities below 20 in both channels. Intensities below 20 in one channel were set to 20 to compensate for extreme quotients. Loess normalization was used///platform_id: GPL5886///contact_name: Karolina,,Partheen///contact_email: karolina.partheen@gu.se///contact_phone: +46+31 342 78 55///contact_fax: +46 +31 41 72 05///contact_department: department of Oncology///contact_institute: University of Gothenburg///contact_address: Bl Strket 2///contact_city: Gothenburg///contact_zip.postal_code: 413 45///contact_country: Sweden///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM311nnn/GSM311988/GSM311988.gpr.gz///data_row_count: 30000"
"GSM311989"	"1658DC"	NA	"tumor"	"ser"	"ov"	NA	NA	"late"	3	"c"	NA	70	"y"	NA	NA	NA	NA	NA	NA	"short"	NA	NA	NA	"suboptimal"	NA	NA	NA	NA	"title: 1658DC///geo_accession: GSM311989///status: Public on Aug 12 2008///submission_date: Aug 12 2008///last_update_date: Aug 13 2008///type: RNA///channel_count: 2///source_name_ch1: serous ovarian adenocarcinoma///organism_ch1: Homo sapiens///characteristics_ch1: fresh frozen tumour///characteristics_ch1.1: deceased///characteristics_ch1.2: stage IIIc///characteristics_ch1.3: macroscopic residual tumor///characteristics_ch1.4: age at diagnosis 70///characteristics_ch1.5: post surgical chemo therapy farmorubicine, carboplatin and cyclophosphamide///molecule_ch1: total RNA///extract_protocol_ch1: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch1: Cy3///label_protocol_ch1: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch1: 9606///source_name_ch2: Universal Human Reference RNA purchased from Stratagene///organism_ch2: Homo sapiens///characteristics_ch2: Reference///molecule_ch2: total RNA///extract_protocol_ch2: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch2: Cy5///label_protocol_ch2: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch2: 9606///hyb_protocol: The probes were purified using ChipShot labelling cleanup system (Promega). The hybridizations were carried out using Pronto! Micro Array reagent systems (Corning Inc.). For each sample, labelled tumour cDNA and reference cDNA were co-precipitated and hybridised to the oligoarray slide.  After hybridization, slides were washed sequential.///scan_protocol: Scanned on an Agilent G2565AA scanner.///scan_protocol.1: Images were quantified using Genepix 6.0.0.74 (Axon Instruments).///description: Comparison of ovarian tumors of 5 year survivors to deceased patients///data_processing: Intensities were calculated by mean spot - median background. Flagged spots were removed as well as spots with intensities below 20 in both channels. Intensities below 20 in one channel were set to 20 to compensate for extreme quotients. Loess normalization was used///platform_id: GPL5886///contact_name: Karolina,,Partheen///contact_email: karolina.partheen@gu.se///contact_phone: +46+31 342 78 55///contact_fax: +46 +31 41 72 05///contact_department: department of Oncology///contact_institute: University of Gothenburg///contact_address: Bl Strket 2///contact_city: Gothenburg///contact_zip.postal_code: 413 45///contact_country: Sweden///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM311nnn/GSM311989/GSM311989.gpr.gz///data_row_count: 30000"
"GSM311990"	"1760LB"	NA	"tumor"	"ser"	"ov"	NA	NA	"late"	3	"b"	NA	40	"y"	NA	NA	NA	NA	NA	NA	"long"	NA	NA	NA	"suboptimal"	NA	NA	NA	NA	"title: 1760LB///geo_accession: GSM311990///status: Public on Aug 12 2008///submission_date: Aug 12 2008///last_update_date: Aug 13 2008///type: RNA///channel_count: 2///source_name_ch1: serous ovarian adenocarcinoma///organism_ch1: Homo sapiens///characteristics_ch1: fresh frozen tumour///characteristics_ch1.1: 5 year survivor///characteristics_ch1.2: stage IIIab///characteristics_ch1.3: macroscopic residual tumor///characteristics_ch1.4: age at diagnosis 40///characteristics_ch1.5: post surgical chemo therapy farmorubicine, carboplatin and cyclophosphamide///molecule_ch1: total RNA///extract_protocol_ch1: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch1: Cy3///label_protocol_ch1: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch1: 9606///source_name_ch2: Universal Human Reference RNA purchased from Stratagene///organism_ch2: Homo sapiens///characteristics_ch2: Reference///molecule_ch2: total RNA///extract_protocol_ch2: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch2: Cy5///label_protocol_ch2: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch2: 9606///hyb_protocol: The probes were purified using ChipShot labelling cleanup system (Promega). The hybridizations were carried out using Pronto! Micro Array reagent systems (Corning Inc.). For each sample, labelled tumour cDNA and reference cDNA were co-precipitated and hybridised to the oligoarray slide.  After hybridization, slides were washed sequential.///scan_protocol: Scanned on an Agilent G2565AA scanner.///scan_protocol.1: Images were quantified using Genepix 6.0.0.74 (Axon Instruments).///description: Comparison of ovarian tumors of 5 year survivors to deceased patients///data_processing: Intensities were calculated by mean spot - median background. Flagged spots were removed as well as spots with intensities below 20 in both channels. Intensities below 20 in one channel were set to 20 to compensate for extreme quotients. Loess normalization was used///platform_id: GPL5886///contact_name: Karolina,,Partheen///contact_email: karolina.partheen@gu.se///contact_phone: +46+31 342 78 55///contact_fax: +46 +31 41 72 05///contact_department: department of Oncology///contact_institute: University of Gothenburg///contact_address: Bl Strket 2///contact_city: Gothenburg///contact_zip.postal_code: 413 45///contact_country: Sweden///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM311nnn/GSM311990/GSM311990.gpr.gz///data_row_count: 30000"
"GSM311991"	"1805DB"	NA	"tumor"	"ser"	"ov"	NA	NA	"late"	3	"b"	NA	82	"y"	NA	NA	NA	NA	NA	NA	"short"	NA	NA	NA	"suboptimal"	NA	NA	NA	NA	"title: 1805DB///geo_accession: GSM311991///status: Public on Aug 12 2008///submission_date: Aug 12 2008///last_update_date: Aug 13 2008///type: RNA///channel_count: 2///source_name_ch1: serous ovarian adenocarcinoma///organism_ch1: Homo sapiens///characteristics_ch1: fresh frozen tumour///characteristics_ch1.1: deceased///characteristics_ch1.2: stage IIIab///characteristics_ch1.3: macroscopic residual tumor///characteristics_ch1.4: age at diagnosis 82///characteristics_ch1.5: post surgical chemo therapy farmorubicine, carboplatin and cyclophosphamide///molecule_ch1: total RNA///extract_protocol_ch1: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch1: Cy3///label_protocol_ch1: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch1: 9606///source_name_ch2: Universal Human Reference RNA purchased from Stratagene///organism_ch2: Homo sapiens///characteristics_ch2: Reference///molecule_ch2: total RNA///extract_protocol_ch2: Homogenization with Trizol followed by total RNA extraction with Rneasy mini kit following manufacturer's instructions (Qiagen).///label_ch2: Cy5///label_protocol_ch2: Probes labelled with Cy3 were synthesized from 5 g of the total tumour RNA and reference labelled with Cy5 were synthesized from 5 g of commercial reference RNA by reverse transcription.///taxid_ch2: 9606///hyb_protocol: The probes were purified using ChipShot labelling cleanup system (Promega). The hybridizations were carried out using Pronto! Micro Array reagent systems (Corning Inc.). For each sample, labelled tumour cDNA and reference cDNA were co-precipitated and hybridised to the oligoarray slide.  After hybridization, slides were washed sequential.///scan_protocol: Scanned on an Agilent G2565AA scanner.///scan_protocol.1: Images were quantified using Genepix 6.0.0.74 (Axon Instruments).///description: Comparison of ovarian tumors of 5 year survivors to deceased patients///data_processing: Intensities were calculated by mean spot - median background. Flagged spots were removed as well as spots with intensities below 20 in both channels. Intensities below 20 in one channel were set to 20 to compensate for extreme quotients. Loess normalization was used///platform_id: GPL5886///contact_name: Karolina,,Partheen///contact_email: karolina.partheen@gu.se///contact_phone: +46+31 342 78 55///contact_fax: +46 +31 41 72 05///contact_department: department of Oncology///contact_institute: University of Gothenburg///contact_address: Bl Strket 2///contact_city: Gothenburg///contact_zip.postal_code: 413 45///contact_country: Sweden///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM311nnn/GSM311991/GSM311991.gpr.gz///data_row_count: 30000"
